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SUMMARY	  	  	  	  	  	  	  Establishment	   of	   a	   proper	   chromatin	   landscape	   is	   central	   to	   genome	   function.	   Here,	   we	  explain	  H3	  variant	  distribution	  by	  specific	  targeting	  and	  dynamics	  of	  deposition	  involving	  the	  CAF-­‐1	  and	  HIRA	  histone	  chaperones.	  Impairing	  replicative	  H3.1	  incorporation	  via	  CAF-­‐1	  enables	  an	  alternative	  H3.3	  deposition	  at	  replication	  sites	  via	  HIRA.	  Conversely,	  the	  H3.3	  incorporation	   throughout	   the	   cell	   cycle	   via	   HIRA	   cannot	   be	   replaced	   by	   H3.1.	   ChIP-­‐seq	  analyses	  reveal	  correlation	  between	  HIRA-­‐dependent	  H3.3	  accumulation	  and	  RNA	  pol	  II	  at	  transcription	  sites	  and	  specific	  regulatory	  elements,	  further	  supported	  by	  their	  biochemical	  association.	  The	  HIRA	  complex	  shows	  unique	  DNA	  binding	  properties	  and	  depleting	  HIRA	  increases	  DNA	  sensitivity	  to	  nucleases.	  We	  propose	  that	  protective	  nucleosome	  gap-­‐filling	  of	  naked	  DNA	  by	  HIRA	  leads	  to	  a	  broad	  distribution	  of	  H3.3,	  and	  HIRA	  association	  with	  Pol	  II	  ensures	   local	  H3.3	  enrichment	  at	  specific	  sites.	  We	  discuss	   the	   importance	  of	   this	  H3.3	  deposition	  as	  a	  salvage	  pathway	  to	  maintain	  chromatin	  integrity.	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INTRODUCTION	  Distinct	   histone	   variants	   mark	   specific	   chromatin	   states	   (Kouzarides,	   2007;	   Talbert	   and	  Henikoff,	  2010)	  however	  the	  mechanisms	  used	  to	  achieve	  this	  defined	  distribution	  remain	  unclear.	   In	  mammals,	   several	   histone	  H3	  variants	  have	  been	   identified	   among	  which	   the	  replicative	  and	  replacement	  variants,	  H3.1	  and	  H3.3,	  respectively,	  show	  only	  5	  amino	  acids	  difference	  (Szenker	  et	  al.,	  2011).	  The	  increased	  expression	  of	  replicative	  histones	  during	  S	  phase	  ensures	  the	  major	  source	  of	  histones	  during	  replication	  (Corpet	  and	  Almouzni,	  2009;	  Groth	  et	  al.,	  2007;	  Kaufman	  and	  Rando,	  2010).	   In	  contrast,	   the	  constitutive	  expression	  of	  the	   replacement	   H3.3	   variant	   throughout	   the	   cell	   cycle	   and	   in	   quiescence	   provides	   a	  continuous	  source	   in	  all	   instances	  (Wu	  et	  al.,	  1982).	  While	  H3.3	   is	  highly	  enriched	  within	  actively	  transcribed	  genes	  (Jin	  et	  al.,	  2009;	  Mito	  et	  al.,	  2005;	  Wirbelauer	  et	  al.,	  2005),	  its	  use	  during	   sperm	   reprogramming	   (Loppin	   et	   al.,	   2005;	   Torres-­‐Padilla	   et	   al.,	   2006;	   van	   der	  Heijden	  et	  al.,	  2005)	  as	  well	  as	  its	  accumulation	  at	  telomeric	  (Goldberg	  et	  al.,	  2010;	  Wong	  et	  al.,	  2009)	  and	  pericentric	  heterochromatin	  (Drané	  et	  al.,	  2010)	  suggest	  various	  means	  for	  H3.3	  deposition	  independent	  of	  transcription.	  	  	  	   Histone	  chaperones	  are	  currently	  considered	  the	  most	  likely	  candidates	  responsible	  for	   specific	   histone	   variant	   deposition	   (De	  Koning	   et	   al.,	   2007;	   Ray-­‐Gallet	   and	  Almouzni,	  2010).	  The	  respective	  presence	  of	  chromatin	  assembly	  factor-­‐1	  (CAF-­‐1)	  with	  H3.1	  and	  the	  histone	  regulator	  A	  (HIRA)	  complex	  with	  H3.3	  in	  soluble	  complexes	  have	  implicated	  these	  histone	  chaperones	  in	  the	  specific	  deposition	  of	  these	  variants	  (Tagami	  et	  al.,	  2004).	  CAF-­‐1	  consists	   of	   three	   subunits	   p150,	   p60	   and	   p48	   and	   promotes	   histone	   deposition	   during	  replication	   and	   UV-­‐damage	   repair	   (Gaillard	   et	   al.,	   1996;	   Polo	   et	   al.,	   2006;	   Smith	   and	  Stillman,	  1989).	  In	  contrast	  to	  CAF-­‐1,	  HIRA	  promotes	  histone	  deposition	  independently	  of	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DNA	  synthesis	  as	  shown	  in	  X.	  laevis	  egg	  extracts	  (Ray-­‐Gallet	  et	  al.,	  2002).	  Recent	  data	  show	  that	   HIRA	   is	   in	   a	   complex	   that	   also	   contains	   calcineurin-­‐binding	   protein	   1	   (Cabin1)	   and	  ubinuclein	  1	  (UBN1)	  (Balaji	  et	  al.,	  2009;	  Banumathy	  et	  al.,	  2009;	  Elsaesser	  and	  Allis,	  2010;	  Rai	   et	   al.,	   2011).	   	   Notably,	   these	   three	   components	   have	   counterparts	   in	   yeast	   that	  constitute	  the	  HIR	  complex	  (Amin	  et	  al.,	  2011).	  More	  recently,	  the	  report	  of	  other	  separate	  H3.3	  chaperones,	  namely	  DEK	  (Sawatsubashi	  et	  al.,	  2010)	  and	  a	  complex	  comprised	  of	  the	  death-­‐associated	   protein	   (DAXX)	   and	   the	   alpha-­‐thalassemia/mental	   retardation	   X-­‐linked	  syndrome	   protein	   (ATRX)	   (Drané	   et	   al.,	   2010;	   Goldberg	   et	   al.,	   2010;	   Lewis	   et	   al.,	   2010;	  Wong	   et	   al.,	   2010)	   have	   raised	   the	   possibility	   that,	   beside	   the	   HIRA-­‐dependent	   process,	  additional	   pathways	   could	   contribute	   to	   distinct	   H3.3	   local	   enrichment.	   The	   recurrent	  observation	  that	  histone	  chaperones	  regulation	  is	  affected	  in	  cancer,	  with	  CAF-­‐1	  and	  Asf1b	  marking	  aggressive	  breast	  tumours	  (Corpet	  et	  al.,	  2011;	  Polo	  and	  Almouzni,	  2005;	  Polo	  et	  al.,	   2010),	  DEK	  rearrangement	   in	  acute	  myeloid	   leukemia	   (von	  Lindern	  et	  al.,	   1992),	   and	  mutation	  in	  DAXX/ATRX	  in	  pancreatic	  neuroendocrine	  tumors	  (Jiao	  et	  al.,	  2011)	  underline	  the	   importance	   of	   understanding	   how	   their	   handling	   of	   histones	   possibly	   relate	   to	  tumorigenesis.	  	   Recent	   advances	   using	   chromatin	   immunoprecipitation	   combined	   with	   high-­‐throughput	   analysis	   using	   microarrays	   or	   deep	   sequencing	   (ChIP-­‐seq)	   have	   enabled	   a	  global	   view	   of	   histone	   variant	   dynamics	   and	   enrichment	   at	   particular	   genomic	   regions.	  Combination	   of	   these	   analyses	   with	   knock-­‐out	   experiments	   in	   mouse	   ES	   cells,	   recently	  revealed	  that	  HIRA	  has	  a	  critical	  role	  for	  H3.3	  accumulation	  at	  promoters,	  active	  genes	  and	  particular	   regulatory	   elements,	   distinct	   from	   DAXX/ATRX	   which	   has	   been	   implicated	   in	  H3.3	  enrichment	  at	  telomeres	  (Goldberg	  et	  al.,	  2010).	  While	  an	  enrichment	  profile	  reflects	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the	   accumulation	  of	   a	   histone	   variant	   in	   a	   steady	   state	   at	   an	   endpoint,	   it	   is	   important	   to	  realize	  that	  this	  enrichment	  is	  the	  result	  of	  the	  combined	  events	  of	  deposition,	  eviction	  and	  maintenance.	   Thus,	   to	   fully	   define	  which	   of	   these	   events	   can	   be	   affected	   by	   a	   particular	  factor,	  it	  is	  necessary	  to	  develop	  an	  appropriate	  technology	  in	  which	  a	  distinction	  between	  new	   and	   old	   histones	   can	   be	   made.	   In	   this	   respect,	   a	   new	   method	   termed	   CATCH-­‐IT	  (covalent	   attachment	   of	   tags	   to	   capture	   histones	   and	   identify	   turnover)	   enabled	   the	  measurement	  of	  incorporation	  and	  turnover	  rates	  of	  newly	  synthesized	  histones	  genome-­‐wide	   in	   Drosophila	   cells	   (Deal	   et	   al.,	   2010).	   However,	   this	   technique	   provides	   only	   an	  average	  picture	   across	   a	   cell	   population,	   rather	   than	  on	   a	   cell-­‐by-­‐cell	   basis	   and	  does	  not	  distinguish	  between	  histone	  variants.	  A	  unique	  and	  alternative	  strategy	  employs	  the	  SNAP-­‐tag,	   a	   small	   self	   labeling	   enzyme	   that	   can	  be	   fluorescently	  pulse	   labeled	   in	  vivo.	  Here	  we	  apply	  SNAP-­‐tag	  technology	  for	  visualization	  of	  specific	  newly	  synthesized	  tagged	  histones	  on	  a	  cell-­‐by-­‐cell	  basis	  (Keppler	  et	  al.,	  2003).	  Indeed,	  this	  approach	  has	  proven	  powerful	  in	  following	   the	   inheritance	   and	   deposition	   of	   the	   specific	   H3	   variant	   CENP-­‐A	   during	   late	  mitosis	  (Dunleavy	  et	  al.,	  2011;	  Foltz	  et	  al.,	  2009;	  Jansen	  et	  al.,	  2007).	  	   Using	   the	  SNAP-­‐tag	   technology	   combined	  with	  genome	  wide	  analysis,	  we	   study	   in	  
vivo	   deposition	   of	   H3.1	   and	   H3.3	   histone	   variants.	   By	   exploiting	   this	   approach,	   both	  qualitatively	  on	  a	  cell-­‐by-­‐cell	  basis	  and	  quantitatively	  on	  a	  population	  of	  cells,	  we	  provide	  a	  novel	  view	  concerning	  how	  CAF-­‐1-­‐	  and	  HIRA-­‐mediated	  deposition	  pathways	  can	  be	  inter-­‐related	  and	  how	  the	  HIRA	  complex	  can	  be	  targeted	  for	  H3.3	  incorporation.	  Based	  on	  these	  data,	  we	  discuss	  how	  the	  HIRA-­‐dependent	  H3.3	  deposition	  can	  act	  as	  a	  salvage	  pathway	  to	  maintain	  chromatin	  integrity	  at	  any	  place	  where	  nucleosomal	  organization	  is	  compromised	  and	  how	  this	  impacts	  on	  genome	  function.	  	  
	   6	  
RESULTS	  
	  
An	  in	  vivo	  visualization	  assay	  for	  newly	  synthesized	  H3.1	  and	  H3.3	  deposition	  To	   monitor	   newly	   synthesized	   histone	   deposition	   in	   vivo,	   we	   used	   two	   HeLa	   cell	   lines	  stably	  expressing	  respectively	  H3.1	  or	  H3.3	  tagged	  with	  three	  HA	  epitopes	  and	  SNAP.	  The	  SNAP	   polypeptide	   reacts	   covalently	   in	   vivo	   with	   cell-­‐permeable	   fluorescent	   or	   non-­‐fluorescent	   substrates	   and	   enables	   specific	   visualization	   of	   newly	   synthesized	   histones	  (Jansen	   et	   al.,	   2007)	   (see	   scheme	   Figure	   S1).	   We	   first	   validated	   in	   both	   cell	   lines	   the	  efficiency	   of	   our	   in	   vivo	   deposition	   assay	   based	   on	   "Quench-­‐Chase-­‐Pulse"	   labeling.	  Microscopy	  analysis	  (Figure	  1A)	  shows	  that	  the	  "Pulse"	  labeled	  both	  pre-­‐existing	  H3.1	  and	  H3.3	  effectively	  while	  the	  "Quench-­‐Pulse"	  gives	  only	  background	  confirming	  the	  efficiency	  of	   quenching.	   The	   "Quench-­‐Chase-­‐Pulse"	   shows	   a	   reduced	   TMR-­‐Star	   staining	   consistent	  with	   the	   short	   pulse	   labeling	   of	   newly	   synthesized	   histones	   when	   compared	   to	   the	   one	  corresponding	  to	  all	  pre-­‐existing	  tagged	  histones.	  Part	  of	  the	  newly	  synthesized	  histones	  is	  not	   solubilized	   by	   detergent	   extraction	   reflecting	   their	   incorporation	   into	   chromatin.	   To	  quantify	   the	  distinct	  histone	  populations,	  using	  extracts	   from	  the	  same	  cells,	  we	  resolved	  proteins	   by	   gel	   electrophoresis	   and	   analyzed	   the	   fluorescently	   pulse	   labeled	   bands	  corresponding	  to	  the	  different	  forms	  of	  H3.1	  and	  H3.3	  (Figure	  1B).	  We	  found	  a	  comparable	  value	   for	   the	   proportion	   of	   total	   newly	   synthesized	   tagged	   histones	   H3.1	   and	   H3.3	   (the	  ratio	   of	   new	   total	   histones	   H3.1/H3.3	   is	   0.88)	   as	   expected	   for	   an	   ectopically	   driven	  expression	   for	  both	   tagged	  histones	   throughout	   the	   cell	   cycle.	  However,	   the	   ratio	  of	  new	  incorporated	  histones	  H3.1/H3.3	  is	  0.53	  reflecting	  the	  more	  limited	  incorporation	  of	  H3.1	  restricted	  to	  replicating	  cells,	  whereas	  deposition	  of	  H3.3	  occurs	  throughout	  the	  cell	  cycle	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(see	  below).	  It	  is	  interesting	  to	  note	  though	  that	  if	  one	  would	  consider	  that	  the	  efficiency	  of	  deposition	  was	  perfectly	  equal	   for	  both	  variants,	   then	   this	  number	  should	  be	  even	   lower	  given	  that	  S	  phase	  represents	  about	  40%	  of	  total	  cells.	  This	  indicates	  that,	  while	  restricted	  to	  S	  phase,	  H3.1	  deposition	  involves	  a	  potent	  deposition	  mechanism.	  	   We	  conclude	  that	  cell	  lines	  expressing	  SNAP-­‐tagged	  histones	  are	  a	  powerful	  tool	  to	  analyze	   in	  vivo	   the	  mechanisms	  of	  de	  novo	   deposition	  of	  newly	   synthesized	  H3.1	  or	  H3.3	  both	   at	   an	   individual	   cell	   level	   and	   in	   a	   quantitative	   manner	   using	   the	   "Quench-­‐Chase-­‐Pulse"	  assay.	  	  
Newly	  deposited	  H3.1	  overlaps	  with	  the	  replication	  sites	  in	  vivo,	  while	  H3.3	  does	  not	  To	  further	  analyze	  incorporation	  of	  H3.1	  and	  H3.3	  in	  vivo	  during	  S	  phase,	  we	  exploited	  the	  "Quench-­‐Chase-­‐Pulse"	  validated	  strategy	  combined	  with	  the	  use	  of	  a	  deoxyribonucleotide	  precursor	  EdU	  (5-­‐ethynyl-­‐2'-­‐deoxyuridine)	  to	  detect	  replicating	  cells.	  The	  addition	  of	  EdU	  at	   the	   time	   of	   the	   “Pulse”	   enables	   one	   to	   compare	   incorporation	   of	   newly	   synthesized	  histones	  with	  the	  replication	  sites	  (Figure	  2A).	  The	  replicating	  cells	  (EdU	  positive)	  showed	  a	  strong	  labeling	  with	  newly	  incorporated	  H3.1	  whereas	  in	  the	  non-­‐replicating	  cells	  (EdU	  negative)	  almost	  no	  labeling	  occurred	  (Figure	  2B).	  In	  contrast,	  in	  both	  replicating	  and	  non-­‐replicating	  cells,	  newly	  synthesized	  H3.3	  got	  incorporated	  (Figure	  2B).	  Newly	  incorporated	  H3.1	  strictly	  colocalized	  with	  the	  replication	  sites,	  and	  this	  was	  most	  obvious	  in	  mid	  or	  late	  S	   phase	   (Figure	   2C).	   In	   contrast,	   although	   incorporation	   of	   newly	   synthesized	   H3.3	  occurred	  in	  replicating	  cells,	  the	  labeling	  pattern	  did	  not	  overlap	  with	  replication	  sites,	  as	  best	  observed	  in	  mid	  and	  late	  S	  phase	  (Figure	  2C),	  raising	  the	  interesting	  possibility	  that	  an	  efficient	   H3.1	   deposition	  may	   prevent	   H3.3	   incorporation.	   Furthermore,	  when	   inhibiting	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DNA	   synthesis	   using	   aphidicolin,	   the	   labeling	   of	   newly	   incorporated	   H3.1	   dramatically	  decreased	  when	  compared	  with	  H3.3	  (Figure	  S2).	  	  	   We	   conclude	   that	   the	   de	   novo	   deposition	   of	   H3.1	   occurs	   mainly	   during	   S	   phase	  colocalizing	   with	   replication	   sites,	   whereas	   H3.3	   de	   novo	   deposition	   occurs	   throughout	  interphase	  including	  S	  phase	  without	  overlapping	  with	  replication	  sites.	  	  
Alternative	   deposition	   of	   H3.3	   at	   replication	   sites	   when	   H3.1	   incorporation	   is	  
impaired	  by	  CAF-­‐1	  depletion	  We	   next	   exploited	   our	   in	   vivo	   deposition	   assay	   to	   directly	   assess	   the	   role	   of	   histone	  chaperones	  in	  the	  deposition	  step.	  We	  transfected	  cells	  expressing	  either	  H3.1	  or	  H3.3	  with	  siRNA	  against	   the	  p60	  subunit	  of	   the	  H3.1	  chaperone	  CAF-­‐1	  prior	   to	   the	   "Quench-­‐Chase-­‐Pulse"	  and	  the	   labeling	  of	  replication	  sites	  with	  EdU	  (scheme	  figure	  3A).	  We	  checked	  cell	  cycle	   profiles	   by	   flow	   cytometry	   analysis	   and	   verified	   CAF-­‐1	   p60	   down-­‐regulation	   by	  western	   blot	   analysis	   (Figure	   S3A).	   Newly	   synthesized	   H3.1	   labeling	   decreased	   in	   cells	  depleted	  from	  p60,	  yet	  replicating	  as	  attested	  by	  the	  EdU	  staining	  (Figure	  3B).	  To	  quantify	  these	  data,	   instead	  of	  gel	  analysis	  as	   in	  figure	  1B	  which	  only	  give	  a	  global	  estimation	  and	  cannot	   permit	   to	   selectively	   analyse	   replicating	   cells,	   we	   choose	   a	   microscopic	   method	  using	  image	  acquisitions.	  Notably,	  this	  type	  of	  quantification	  allows	  us	  to	  specifically	  focus	  on	   replicating	   cells	   (EdU	   positive)	   and	   has	   proven	   more	   accurate	   than	   the	   global	   gel	  fluorescence	  analysis	   (see	  experimental	  procedures).	  We	  estimated	  about	  50%	  reduction	  by	   quantification	   of	   TMR	   fluorescence	   intensity	   for	  H3.1	   and	   only	   10%	   for	  H3.3	   in	   p60-­‐depleted	   cells	   (Figure	   3B).	   Comparison	   of	   cytosolic,	   nuclear	   and	   chromatin	   fractions	  further	  supported	  these	  results	  (Figure	  S3D).	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   Remarkably,	  with	   a	   closer	   inspection,	  when	   focusing	   on	   replication	   foci,	  with	   two	  sets	  of	  siRNA	  against	  p60	  we	  could	  detect	  H3.3	   incorporation	  overlapping	  the	  replication	  sites	  marked	   by	   EdU,	   a	   pattern	   not	   detected	   in	   sicont-­‐cells	   (Figures	   3B	   and	   S3C).	  When	  selecting	   EdU	   positive	   cells	   and	   examining	   the	   replication	   foci,	   we	   found	   that	   the	   single	  depletion	   of	   p60	   enabled	   us	   to	   detect	   20%	   of	   replicating	   cells	   that	   exhibited	   an	   overlap	  between	  H3.3	   incorporation	   signal,	   detected	  with	  TMR,	   and	  EdU	   (Figure	  3C).	  To	   identify	  which	  key	  chaperone	  promotes	  this	  unusual	  H3.3	  deposition	  at	  replication	  sites,	  we	  further	  carried	   out	   depletions	   of	   p60	   in	   combination	  with	   either	  HIRA	  or	  DAXX.	  We	   checked	   all	  depletion	   efficiencies	   (Figure	   3C)	   and	   that	   the	   number	   of	   EdU	   positive	   cells	   remained	  comparable	   (Figure	   S3B).	   Codepletion	  of	   p60	   and	  HIRA	   reduced	   this	  20%	  of	   cells	   to	  5%	  while	  15%	  still	  remained	  after	  co-­‐depletion	  of	  p60	  and	  DAXX.	  These	  data	  favour	  the	  HIRA	  complex	  as	  the	  major	  player	  in	  H3.3	  deposition	  at	  replication	  sites	  when	  H3.1	  deposition	  is	  impaired.	  	  	   In	  summary,	  these	  data	  show	  that	  depletion	  of	  CAF-­‐1	  p60	  impairs	  incorporation	  of	  H3.1	   and	   provides	   an	   opportunity	   for	   H3.3	   to	   get	   incorporated	   at	   replication	   sites.	   This	  mechanism	   involving	   HIRA	   may	   provide	   means	   to	   compensate	   at	   least	   in	   part	   for	  	  chromatin	  assembly	  defects.	  
	  
Depletion	   of	   the	   HIRA	   complex	   severely	   affects	   the	   de	   novo	   deposition	   of	   H3.3	  
without	  permitting	  significant	  H3.1	  incorporation	  throughout	  the	  cell	  cycle	  We	   next	   examined	   the	   HIRA	   complex	   components,	   HIRA,	   UBN1	   and	   Cabin1,	   and	   their	  association	  with	  H3.3	  and	  H3.1	  (Figure	  4A,	  left).	  After	  immunoprecipitation	  of	  H3.1	  or	  H3.3	  from	  HeLa	  nuclear	  extracts	  using	  an	  anti-­‐HA	  antibody	  we	   found	  HIRA,	  UBN1	  and	  Cabin1	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co-­‐precipitating	  with	  H3.3	   but	   not	  with	  H3.1.	   In	   contrast,	   CAF-­‐1	   p60	   and	   p150	   subunits	  specifically	  co-­‐immunoprecipitated	  with	  H3.1.	  Moreover,	  antibodies	  directed	  against	  HIRA,	  UBN1	  or	  Cabin1	  co-­‐immunoprecipitated	  all	  three	  proteins	  in	  each	  instance	  but	  not	  CAF-­‐1	  p60,	  confirming	  that	  they	  are	  part	  of	  a	  common	  complex	  (Figure	  4A,	  middle).	  This	  complex	  depends	   on	   HIRA	   since	   siHIRA-­‐treated	   cells	   showed	   a	   concommitant	   decrease	   of	   HIRA,	  UBN1,	   and	   to	   a	   lesser	   extent	   Cabin1	   (Figure	   4A,	   right)	   consistent	   with	   reports	   in	  (Banumathy	  et	  al.,	  2009;	  Rai	  et	  al.,	  2011).	  	   We	   then	   wished	   to	   determine	   the	   importance	   of	   HIRA,	   UBN1	   and	   Cabin1	   in	   the	  deposition	   of	   H3.1	   and	   H3.3.	   For	   this,	   we	   transfected	   cells	   expressing	   H3.1	   and	   H3.3	  (scheme	  figure	  4B)	  with	  siRNA	  against	  HIRA,	  Cabin1	  or	  UBN1	  prior	  to	  the	  "Quench-­‐Chase-­‐Pulse"	  experiment.	  We	  verified	  cell	  cycle	  profiles	  by	  flow	  cytometry	  analysis	  and	  that	  the	  percentage	  of	  EdU	  positive	  cells	  remained	  comparable	  in	  all	  cases	  (Figure	  S4A).	  Depletion	  of	  Cabin1	  did	  not	  decrease	  H3.1	  incorporation	  and	  affected	  H3.3	  deposition	  by	  only	  10%	  as	  shown	   by	  microscopy	   analysis	   followed	   by	   quantification	   of	   TMR	   fluorescence	   intensity	  (Figure	   4C-­‐D).	   	   In	   HIRA	   complex-­‐	   and	   UBN1-­‐depleted	   cells	   we	   observed	   10	   and	   20%	  reduction	   of	   signal	   for	   H3.1,	   respectively	   (Figure	   4C).	   In	   contrast,	   the	   effect	   on	   TMR	  fluorescence	  intensity	  was	  significantly	  stronger	  for	  H3.3	  with	  a	  decrease	  of	  about	  55	  and	  40%	  in	  HIRA	  complex-­‐	  and	  UBN1-­‐depleted	  cells,	  respectively	  (see	  Figure	  4D	  and	  statistics).	  Interestingly,	   we	   could	   not	   detect	   nuclei	   with	   a	   broad	   H3.1	   incorporation	   in	   siHIRA-­‐	   or	  siUBN1-­‐treated	   cells	   indicating	   that	   H3.1	   deposition	   remains	   restricted	   when	   affecting	  H3.3	  deposition.	  Using	  the	  same	  assay,	  we	  found	  that	  DAXX	  and	  ATRX	  depletions	  did	  not	  affect	  H3.3	  deposition	  (Figure	  S5).	  However,	  we	  do	  not	  exclude	   	  other	  role	   for	  DAXX	  and	  ATRX	  in	  H3.3	  deposition	  at	  particular	  loci	  as	  telomeres	  and	  centromeres	  that	  would	  not	  be	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detected	   in	   our	   assay.	  We	   confirmed	   these	   conclusions,	  with	   other	   siRNAs,	   against	  HIRA	  (siHIRA#2)	  (Figure	  S4B)	  and	  UBN1	  (data	  not	  shown),	  and	  by	  comparing	  cytosolic,	  nuclear	  and	  chromatin	  fractions	  (Figure	  S4C-­‐D).	  	  	   Altogether	  our	  data	  demonstrate	  that	   the	  HIRA	  complex	   is	   involved	   in	  the	  de	  novo	  deposition	  of	  H3.3	  in	  vivo.	  While	  Cabin1	  seems	  to	  play	  an	  auxilliary	  role	  in	  our	  deposition	  assay,	   depletion	  of	   the	  HIRA	   complex	   and	   to	   a	   lesser	   extent	  UBN1	  alone	  has	   a	  dominant	  effect	  on	  the	   incorporation	  of	  newly	  synthesized	  H3.3	   in	  vivo	  without	  unleashing	  massive	  H3.1	  incorporation	  outside	  S	  phase.	  	  
A	  link	  between	  HIRA	  complex-­‐dependent	  H3.3	  deposition	  and	  RNA	  polymerase	  II	  The	  HIRA	  dependent	  enrichment	  of	  H3.3	  in	  the	  body	  of	  transcribed	  genes	  and	  at	  CpG	  island	  promoters	   of	   both	   transcribed	   and	   repressed	   genes	   in	   mouse	   ES	   cells	   (Goldberg	   et	   al.,	  2010),	  suggests	  that	  H3.3	  deposition	  may	  be	  linked	  to	  transcription.	  Here,	  in	  human	  HeLa	  cells	  expressing	  H3.3-­‐FLAG-­‐HA	  (Tagami	  et	  al.,	  2004),	  we	  carried	  out	  a	  ChIP-­‐seq	  of	  H3.3	  for	  a	   systematic	   comparison	   with	   a	   previously	   generated	   H3.3	   dataset	   in	   mouse	   ES	   cells	  expressing	  tagged	  endogenous	  H3.3	  (Goldberg	  et	  al.,	  2010).	  In	  Hela	  cells,	  we	  find	  a	  distinct	  H3.3	   density	   profile	   in	   and	   around	   highly	   transcribed	   genes	   (Figure	   5A)	   consistent	  with	  previous	   findings	   (Jin	   et	   al.,	   2009)	  which	   is	   almost	   identical	   in	  mESCs	   (Figure	   5B).	   This	  suggests	   a	  mechanism	   for	  H3.3	   deposition	   in	   transcribed	   genes	   that	   is	   conserved	   across	  species	   and	   cell-­‐types.	   In	   the	   absence	  of	  HIRA,	   the	  H3.3	  density	  pattern	   is	   largely	   lost	   in	  mESCs	   (Figure	   5C)	   (Goldberg	   et	   al.,	   2010),	   confirming	   the	   importance	   of	   HIRA	   in	   H3.3	  enrichment	  at	   these	  sites.	  RNA	  pol	   II	   large	  subunit	   is	   regulated	  by	  phosphorylation	  of	   its	  carboxy	   terminal	   repeats,	   phosphorylation	   at	   Ser5	   being	   associated	   with	   transcription	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initiation	  while	  its	  phosphorylation	  at	  Ser2	  occurs	  during	  elongation	  (Brookes	  and	  Pombo,	  2009;	  Buratowski,	  2009).	  Notably,	  the	  direct	  comparison	  of	  this	  H3.3	  density	  profile	  with	  ChIP-­‐seq	  data	  of	  Ser5P	  and	  Ser2P	  forms	  of	  RNA	  polymerase	  II	  (RNA	  pol	  II)	  in	  mESCs	  (Rahl	  et	   al.,	   2010),	   across	   the	   same	   set	  of	   transcripts,	   displayed	  a	  highly	   similar	  profile	   to	   that	  seen	   for	   H3.3	   (Figure	   5D-­‐E).	   Together,	   these	   enrichment	   profiles	   for	   the	   two	   modified	  forms	   of	   RNA	   pol	   II	   thus	   provide	   correlative	   evidence	   that	   the	   presence	  RNA	   pol	   II	   at	   a	  specific	   genomic	   locus	   directly	   increases	   the	   likelihood	   of	   H3.3	   enrichment,	   in	   a	   HIRA-­‐dependent	  fashion.	  	   In	   addition	   to	   transcriptional	   units,	   H3.3	   was	   found	   enriched	   at	   intergenic	   cis-­‐regulatory	   elements	   in	  mESCs	   (Goldberg	   et	   al.,	   2010).	   In	   the	   same	   study,	   only	   a	   third	   of	  these	  sites	  had	  significantly	  reduced	  H3.3	   levels	  when	  HIRA	  was	  knocked	  out,	  suggesting	  that	   H3.3	   deposition	   at	   many	   regulatory	   elements	   is	   not	   HIRA-­‐dependent.	   We	   thus	  investigated	  closer	  whether	  the	  correlation	  between	  HIRA-­‐dependent	  H3.3	  deposition	  and	  the	  presence	  of	  RNA	  pol	  II	  also	  held	  true	  at	  these	  distal	  cis-­‐regulatory	  elements.	  Using	  a	  set	  of	  genome-­‐wide	  intergenic	  binding	  sites	  for	  13	  transcription	  factors	  in	  mESCs	  (Chen	  et	  al.,	  2008)	  we	  measured	  the	  mean	  change	  in	  H3.3	  enrichment	  in	  wild	  type	  and	  HIRA-­‐deficient	  cells	   for	   each	   set	   of	   binding	   sites	   and	   found	   that	   the	   extent	   of	   this	   change	   differs	  significantly	  between	  factors.	  For	  example,	  E2F1	  and	  SOX2	  binding	  sites	  have	  similar	  levels	  of	  mean	  H3.3	   in	   their	  binding	  sites	   in	  wild-­‐type	  mESCs,	  but	   in	  HIRA-­‐deficient	   cells,	  E2F1	  binding	  sites	  show	  an	  overall	  reduction	  of	  H3.3	  while	  SOX2	  sites	  show	  an	  increase	  (Figures	  5F	  and	  S6).	   Interestingly,	  we	  found	  that	  the	   level	  of	  enrichment	  of	  RNA	  pol	  II	  Ser5P,	  (but	  not	   Ser2P)	   also	  differs	   significantly	  within	   the	  binding	   sites	   of	   these	   factors	   (Figure	  5G).	  Across	  all	  13	  factors,	  we	  found	  a	  significant	  correlation	  (R2	  =	  0.616,	  P=9.06x10-­‐4)	  between	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the	  mean	  level	  of	  RNA	  pol	  II	  Ser5P	  and	  overall	  HIRA-­‐dependency	  of	  H3.3	  within	  the	  binding	  site	  (Figures	  5H	  and	  S6).	  Thus,	  we	  find	  that	  the	  higher	  the	  mean	  level	  of	  RNA	  pol	  II	  Ser5P,	  the	   higher	   the	   mean	   level	   of	   HIRA-­‐dependent	   H3.3	   enrichment	   at	   transciption	   factor	  binding	  sites.	  This	  is	  further	  confirmed	  by	  the	  observation	  that	  the	  level	  of	  H3.3	  enrichment	  at	  binding	  sites	   is	  also	  correlated	  with	   the	  presence	  of	  Pol	   II,	  but	  only	   in	   the	  presence	  of	  HIRA	   (Figure	   S6).	   These	   results	   suggest	   that	   the	   presence	   of	   RNA	   pol	   II	   at	   regulatory	  elements	   can	   at	   least	   partly	   explain	   why	   some	   regulatory	   elements	   have	   more	   HIRA-­‐dependent	  H3.3	  enrichment	  than	  others.	  	  This	   correlation	  between	   the	  HIRA-­‐dependent	   enrichment	   of	  H3.3	   and	  RNA	  pol	   II	  prompted	   us	   to	   ask	   whether	   the	   HIRA	   complex	   is	   associated	   with	   the	   transcriptional	  machinery,	  in	  particular	  with	  the	  largest	  subunit	  of	  RNA	  pol	  II.	  Cabin1	  and	  UBN1	  antibodies	  co-­‐immunoprecipitated	  both	  phosphorylated	  forms	  of	  RNA	  pol	  II	  using	  specific	  antibodies	  recognizing	  either	  Ser2	  or	  Ser5	  phosphorylated	  RNA	  pol	  II	  (Stock	  et	  al.,	  2007),	  but	  not	  CAF-­‐1	  p60	  (Figure	  5I).	  The	  reverse	  immunoprecipitation	  experiments	  showed	  that	  both	  Ser2P	  and	  Ser5P	  RNA	  pol	  II	  antibodies	  co-­‐immunoprecipitated	  the	  three	  components	  of	  the	  HIRA	  complex,	  Cabin1,	  UBN1	  and	  HIRA,	  but	  not	  CAF-­‐1	  p60	  (Figure	  5J).	  From	  these	  results	  we	  conclude	  that	  HIRA-­‐dependent	  H3.3	  enrichment	  at	  genes	  and	  a	   subset	   of	   regulatory	   elements	   correlates	  with	   the	   presence	   of	   RNA	   pol	   II	   and	   that	   the	  HIRA	  complex	  associates	  with	  both	   the	  promoter-­‐associated	  and	   the	  elongating	   forms	  of	  RNA	  pol	  II	  in	  vivo.	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The	   HIRA	   complex	   binds	   directly	   to	   DNA	   and	   its	   depletion	   increases	   DNase	  
sensitivity	  While	  the	  association	  of	  the	  HIRA	  complex	  with	  RNA	  pol	  II	  can	  explain	  the	  H3.3	  enrichment	  at	   genes	   and	   a	   subset	   of	   regulatory	   elements,	   the	   observation	   of	   H3.3	   incorporation	   at	  replication	  sites	  when	  H3.1	  deposition	   is	   impaired	  (Figure	  3)	   indicates	  that	  at	   least	  some	  H3.3	  incorporation	  likely	  occurs	  independently	  of	  RNA	  pol	  II.	  This	   is	   further	  underscored	  by	   the	   large	   scale	   transcription-­‐independent	  HIRA-­‐mediated	  H3.3	  deposition	   in	   the	  male	  pronucleus	  following	  fertilization	  (Loppin	  et	  al.,	  2005;	  Torres-­‐Padilla	  et	  al.,	  2006;	  van	  der	  Heijden	   et	   al.,	   2005)	   indicating	   the	   possibility	   of	   an	   alternative	   mode	   of	   targeting.	   A	  common	  feature	  in	  both	  cases	  is	  the	  exposure	  of	  non-­‐nucleosomal/naked	  DNA	  which	  thus	  potentially	   represents	   a	   direct	   target	   for	   HIRA-­‐mediated	   H3.3	   deposition.	   One	   can	  therefore	  envisage,	  in	  the	  simplest	  scenario	  that	  this	  is	  promoted	  by	  a	  capacity	  of	  the	  HIRA	  complex	  to	  bind	  naked	  DNA.	  To	  test	  this	  hypothesis,	  using	  plasmid	  DNA	  fixed	  on	  magnetic	  beads,	  we	  found	  that	  HIRA,	  UBN1	  and	  Cabin1	  from	  nuclear	  extracts	  could	  readily	  bind	  DNA	  in	  contrast	   to	  any	  of	   the	  other	  histone	  chaperones	  examined	   in	  parallel	   (Figure	  6A).	  This	  includes	  p48,	  p60	  and	  p150	  subunits	  of	  CAF-­‐1,	  Asf1a/b	  and	  NASP	  that	  have	  been	  identified	  in	   both	   H3.1	   and	   H3.3	   complexes	   (Tagami	   et	   al.,	   2004),	   spt6	   and	   spt16	   (FACT	   subunit)	  known	  to	  be	  linked	  with	  the	  transcriptional	  machinery	  (Sims	  et	  al.,	  2004),	  DEK,	  ATRX	  and	  DAXX.	  	  Furthermore,	  RNA	  pol	  II	  (Ser5P	  and	  Ser2P)	  exhibited	  only	  low	  DNA	  binding	  in	  these	  conditions,	  arguing	  that	  the	  binding	  of	   the	  HIRA	  complex	  to	  DNA	  is	   likely	   independent	  of	  RNA	   pol	   II.	   We	   thus	   further	   tested	   if	   a	   reconstituted	   recombinant	   HIRA	   complex	   could	  indeed	  bind	  to	  DNA	  directly.	  Our	  data	  in	  figure	  6B	  confirmed	  that	  the	  HIRA	  complex	  on	  its	  own	   also	   showed	   direct	   DNA	   binding	   ability	   without	   any	   apparent	   sequence	   specificity.	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Furthermore,	   each	   recombinant	   proteins	   individually	   UBN1,	   Cabin1	   and	   HIRA,	   could	   all	  bind	  DNA	  directly	  in	  contrast	  with	  Asf1a	  (Figure	  6C).	  An	  attractive	  hypothesis	  is	  thus	  that	  any	  destabilized	  nucleosomal	  DNA	  region	  could	  represent	  targets	  for	  the	  HIRA	  complex	  to	  reset	   a	   nucleosomal	   organization.	   In	   this	   scheme,	   one	   would	   thus	   expect	   that	   HIRA	  depletion	   should	   lead	   to	   an	   increased	  genome	  accessibility.	  We	  used	  DNase	  digestion	  on	  nuclei	  from	  siHIRA-­‐	  and	  sicont-­‐treated	  cells	  and	  compared	  the	  resulting	  products	  after	  gel	  analysis.	  The	  digestion	  profiles	  obtained	   for	   two	  separate	   sets	  of	   siRNA	  showed	  a	  higher	  proportion	  of	  smaller	  fragments	  in	  the	  nuclei	  from	  siHIRA-­‐treated	  cells	  when	  compared	  to	  control	  sample	  (Figure	  6D).	  	   We	   conclude	   that	   the	   HIRA	   complex	   is	   unique	   among	   the	   other	   H3-­‐H4	   histone	  chaperones	   tested	   in	   exhibiting	   an	   ability	   to	   directly	   bind	   naked	  DNA.	   Furthermore,	   the	  increased	   DNase	   sensitivity	   observed	   in	   HIRA	   complex-­‐depleted	   cells	   argues	   that	   non-­‐nucleosomal/naked	   DNA	   should	   be	   considered	   as	   a	   valid	   target	   for	   a	   nucleosome	   gap-­‐filling	  mechanism	  at	  any	  place	  in	  the	  genome.	  Taken	  together,	  this	  reveals	  a	  protective	  role	  leading	  to	  a	  broad	  incorporation	  of	  H3.3	  throughout	  the	  genome.	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DISCUSSION	  
	  Our	   comprehensive	   analysis	   of	  H3.1	   and	  H3.3	   deposition	   in	  vivo	   provides	   a	   view	   for	   the	  inter-­‐relation	   between	   CAF-­‐1	   and	   HIRA-­‐mediated	   pathways	   to	   contribute	   to	   unique	  chromatin	   landscapes	   as	   depicted	   in	   our	   model	   (Figure	   7).	   The	   CAF-­‐1-­‐mediated	   H3.1	  deposition	  pathway	   is	   strictly	   limited	   to	   sites	  of	  DNA	  synthesis	   and	  does	  not	   replace	   the	  incorporation	  of	  H3.3	   throughout	   the	   cell	   cycle.	  The	  HIRA	   complex	  plays	   a	  major	   role	   in	  H3.3	  deposition	  throughout	  the	  cell	  cycle	  and	  can	  introduce	  H3.3	  at	  replication	  sites	  when	  replicative	  H3.1	   incorporation	   is	   impaired.	  The	  DNA	  binding	  ability	  of	   the	  HIRA	  complex	  and	   DNase	   sensitivity	   in	   HIRA-­‐depleted	   cells	   unveils	   a	   potential	   nucleosome	   gap-­‐filling	  mechanism	   for	   HIRA-­‐dependent	   H3.3	   deposition	   apparently	   without	   any	   sequence	  specificity.	  Furthermore,	  its	  association	  with	  Pol	  II	  may	  aid	  the	  targeting	  of	  H3.3	  to	  sites	  of	  transcription	  or	  regulatory	  elements.	  	  
Balance	   between	   CAF-­‐1-­‐dependent	   H3.1	   deposition	   and	   HIRA-­‐dependent	   H3.3	  
deposition	  	  in	  vivo	  The	  original	  model	  of	  a	  replication-­‐coupled	  (RC)	  mechanism	  for	  canonical	  H3.1	  deposition	  and	  both	  RC	  and	  replication-­‐independent	  (RI)	  mechanisms	  for	  H3.3	  deposition	  was	  based	  on	  early	  reports	  in	  Drosophila	  cells	  (Ahmad	  and	  Henikoff,	  2002).	  Here,	  beyond	  confirming	  this	   general	   view,	   we	   further	   provide	   mechanistic	   insights	   into	   specific	   targeting	   and	  dynamics	  of	  deposition	  involving	  the	  CAF-­‐1	  and	  HIRA	  histone	  chaperones.	  First,	  we	  reveal	  that,	  during	  S	  phase,	  deposition	  of	  newly	  synthesized	  H3.1	  colocalizes	  with	  the	  replication	  sites	   in	   a	   DNA	   synthesis-­‐coupled	   (DSC)	   manner,	   whereas	   newly	   synthesized	   H3.3	   is	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excluded	  from	  sites	  of	  DNA	  synthesis	  under	  normal	  circumstances.	  Second,	  although	  H3.3	  can	   be	   incorporated	   during	   S	   phase,	   this	   process	   is	  DNA	   synthesis-­‐independent	   (DSI)	   as	  long	  as	  the	  H3.1	  deposition	  pathway	  is	  intact.	  	  	   Moreover,	   after	  downregulation	  of	   the	  histone	   chaperone	  CAF-­‐1	  p60,	   a	   significant	  number	  of	  cells	  exhibited	  a	  deposition	  pattern	  for	  H3.3	  that	  overlapped	  with	  EdU	  labeling.	  Thus,	   these	   cells	   are	   able	   to	   switch	   to	   H3.3	   deposition	   onto	   replicating	   DNA	  when	  H3.1	  cannot	   be	   incorporated.	   Importantly,	   the	   fact	   that	   the	   co-­‐depletion	   of	   p60	   and	   HIRA	  decreased	   the	   number	   of	   cells	   exhibiting	   newly	   incorporated	   H3.3	   at	   replication	   sites	  makes	  the	  HIRA	  complex	  a	  prime	  candidate	  for	  this	  H3.3	  alternative	  mechanism.	  To	  which	  extent	   this	   alternative	   mechanism	   can	   be	   compensatory	   remains	   to	   be	   established.	  Interestingly,	  the	  use	  of	  H3.3	  in	  an	  alternative	  pathway	  is	  consistent	  with	  the	  fact	  that	  high	  H3.3	  expression	  in	  the	  protozoa	  Tetrahymena	  allows	  growth	  in	  the	  absence	  of	  canonical	  H3	  (Cui	  et	  al.,	  2006).	  Our	  data	  however,	  do	  not	  support	   the	  use	  of	  H3.1	   in	  place	  of	  H3.3	  as	  a	  converse	  alternative	  mechanism,	  perhaps	  because	  our	  system	  does	  not	  overproduce	  H3.1.	  Again,	   this	   is	   supported	   in	   Tetrahymena,	   where	   cells	   deficient	   in	   H3.3	   cells	   do	   not	   use	  canonical	  H3	  for	  DSI	  assembly	  even	  in	  absence	  of	  H3.3	  (Cui	  et	  al.,	  2006).	  This	  unidirectional	  replacement/alternative	   mechanism	   may	   therefore	   reflect	   a	   conserved	   and	   possibly	  ancient	   function	   of	   H3.3	   (Szenker	   et	   al.,	   2011).	   Intriguingly,	   in	   flies	   deficient	   for	   H3.3,	  canonical	   H3	   gets	   overexpressed	   and	   incorporates	   in	   a	   DSI	  manner	   (Sakai	   et	   al.,	   2009),	  suggesting	  some	  parsimonious	   function	  of	   the	  deposition	  pathways.	   If	   such	  a	  mechanism	  occurs	  in	  our	  system,	  without	  massive	  unbalancing	  of	  H3	  variants,	   it	  remains	  beyond	  our	  detection	  limits.	  Furthermore,	  these	  overall	  data	  suggest	  that	  the	  limiting	  step	  is	  whether	  the	  actual	  deposition	  pathways	  can	  be	  targeted	  where	  it	  is	  needed.	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   Together	   our	   data	   emphasize	   the	   possibility	   of	   H3.3	   incorporation	   via	   HIRA	   at	  replication	   sites	   when	   H3.1	   deposition	   is	   impaired.	   This	   finding	   reflects	   a	   potential	   for	  restoration	  of	  nucleosomal	  organization	  during	  replication	  using	  any	  available	  H3	  variants	  to	  ensure	  maintenance	  of	  chromatin	  stability.	  	  
HIRA	  is	  a	  major	  histone	  chaperone	  complex	  involved	  in	  H3.3	  deposition	  in	  vivo	  Our	   deposition	   assay	   demonstrates	   that	   HIRA,	   as	   a	   complex,	   is	   a	   critical	   actor	   in	   the	  incorporation	  of	  H3.3	  throughout	  the	  cell	  cycle	  with	  a	  broad	  genome	  coverage.	  Remarkably,	  the	   defect	   in	   H3.3	   deposition	   following	   UBN1	   down-­‐regulation	   indicates	   that	   the	   sole	  presence	  of	  HIRA	  and	  Cabin1	  is	  not	  sufficient	  for	  efficient	  H3.3	  incorporation.	  The	  stronger	  defect	  with	  siRNA	  treatment	  against	  HIRA,	  further	  underlines	  the	  importance	  of	  HIRA	  and	  the	   overall	   complex.	   Indeed,	   we	   found	   that	   the	   presence	   of	   HIRA	   is	   important	   for	   the	  stability	  of	  UBN1	  and	  Cabin1,	  providing	   further	  evidence	  for	   their	  role	  as	  a	  complex.	  The	  most	   striking	   defects	   in	   H3.3	   deposition	   in	   both	   non-­‐replicating	   and	   replicating	   cells	  following	  siHIRA-­‐	  and	  siUBN1-­‐treatment	  demonstrate	  their	  critical	  role	  for	  H3.3	  deposition	  both	  during	  and	  outside	  S	  phase.	  The	  role	  of	  Cabin1,	  given	  that	  its	  down-­‐regulation	  did	  not	  significantly	  affect	  H3.3	  deposition	  may	  be	  in	  controlling	  the	  availability	  of	  H3.3	  rather	  than	  its	  actual	  deposition	  as	  suggested	  by	  the	  increased	  amount	  of	  soluble	  H3.3	  in	  Cabin1-­‐down-­‐regulated	   cells	   (Figure	   S4D).	   It	   is	   noteworthy	   that	   no	   ortholog	   of	   this	   subunit	   has	   been	  identified	   in	   Drosophila	   so	   far.	   Taken	   together,	   we	   conclude	   that	   HIRA	   is	   a	   central	  component	   for	  the	  function	  of	   the	  complex	  to	  ensure	  H3.3	  deposition	  throughout	  the	  cell	  cycle.	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HIRA-­‐dependent	  H3.3	  deposition	  at	  Pol	  II	  sites	  
	  The	   enrichment	   of	   the	  histone	   variant	  H3.3	   at	   transcriptionally	   active	   regions	   in	   various	  metazoans	  (Goldberg	  et	  al.,	  2010;	  Jin	  et	  al.,	  2009;	  Mito	  et	  al.,	  2005)	  and	  the	  dependency	  of	  this	   on	   HIRA	   in	   mouse	   ES	   cells	   suggests	   a	   close	   association	   between	   HIRA	   and	   the	  transcriptional	  machinery.	   In	  support	  of	   this,	  we	   found	  that	   the	  HIRA	  complex	  associates	  with	  both	  initiating	  (Ser5P)	  and	  elongating	  (Ser2P)	  forms	  of	  RNA	  pol	  II	  in	  vivo.	  Whether	  the	  HIRA-­‐Pol	  II	   interaction	  is	  direct	  or	  mediated	  by	  another	  component	  of	  the	  transcriptional	  machinery	   remains	   to	   be	   addressed.	   Furthermore,	   this	   association	   is	   also	   strongly	  supported	   by	   striking	   similarities	   in	   ChIP-­‐seq	   enrichment	   profiles	   of	   H3.3	   and	   Pol	   II	   in	  transcribing	  regions,	  at	  the	  promoter	  and	  downstream	  of	  the	  TTS.	  These	  are	  regions	  where	  Pol	  II	   is	  known	  to	  be	  paused	  for	  significant	  periods	  of	  time,	  during	  Ser5P	  initiation	  at	  the	  promoter,	  or	  0.5-­‐1.5kb	  downstream	  of	  the	  TTS	  where	  Ser2P	  recruits	  3'	  processing	  factors	  (Core	   and	   Lis,	   2008;	   Glover-­‐Cutter	   et	   al.,	   2008).	   Remarkably,	   the	   correlation	   of	   HIRA-­‐dependent	  H3.3	  deposition	  and	  Pol	   II	   remains	   true	  even	   in	   intergenic	   regulatory	   regions	  corresponding	   to	   specific	   transcription	   factor	   binding	   sites.	   Thus,	   these	   data	   suggest	   an	  important	  role	  for	  the	  association	  of	  Pol	  II	  and	  HIRA	  in	  promoting	  local	  H3.3	  enrichment.	  	  	  
HIRA-­‐dependent	  H3.3	  deposition	  by	  nucleosome	  gap-­‐filling	  	   In	  addition	   to	   targeted	   local	  deposition,	  we	  discovered	   that	   the	  HIRA	  complex	  can	  bind	   to	   naked	   DNA,	   whereas	   the	   other	   histone	   chaperones	   that	   we	   tested	   did	   not.	   This	  uncovers	  an	  alternative	  mode	  of	  HIRA	  dependent	  H3.3	  deposition	  at	  any	  region	  where	  non-­‐nucleosomal/naked	  DNA	  is	  accessible,	  that	  could	  differ	  from	  one	  cell	  to	  the	  next	  and	  thus	  would	  not	  have	  been	  picked	  up	  in	  analyzing	  genome-­‐wide	  H3.3	  enrichment	  profiles.	  This	  is	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supported	   by	   the	   higher	   sensititivity	   observed	   in	   our	   assay	   for	   DNA	   accessibility	   using	  DNase	   digestion	   on	   nuclei	   isolated	   from	   cells	   depleted	   of	   the	   HIRA	   complex.	   Thus	   H3.3	  distribution	  is	  not	  simply	  reflecting	  active	  transcription	  but	  rather	  reflects	  the	  deposition	  pathway	   available.	   This	   could	   explain	  how	  HIRA	  participates	   in	   large	   scale	   deposition	  of	  H3.3	  on	  the	  paternal	  pronucleus	  after	  fertilization	  in	  Drosophila	  (Loppin	  et	  al.,	  2005)	  and	  in	  mouse	  embryos	  (Santenard	  et	  al.,	  2010;	  Torres-­‐Padilla	  et	  al.,	  2006;	  van	  der	  Heijden	  et	  al.,	  2005).	   Interestingly,	   the	  yeast	  homolog	  of	   the	  HIRA	  complex	  as	  well	  as	  Yemanuclein,	   the	  drosophila	   homolog	   of	   UBN1,	   also	   exhibit	   DNA	   binding	   ability	   suggesting	   this	   is	   a	  conserved	  property	  (Ait-­‐Ahmed	  et	  al.,	  1992;	  Prochasson	  et	  al.,	  2005).	  Furthermore,	  HIRA,	  UBN1	  and	  Cabin1	   recombinant	  proteins	  bound	  DNA	   individually	   in	  vitro,	   	   indicating	   that	  each	  of	  them	  may	  participate	  in	  targeting	  the	  HIRA	  complex	  for	  H3.3	  deposition	  in	  vivo.	  	  In	  contrast,	  H3.3	   chaperones	  ATRX	  and	  DAXX	  do	  not	   exhibit	   significant	   levels	   of	   binding	   to	  random	  DNA,	  but	  ATRX	  is	  known	  to	  show	  a	  preference	  for	  sequences	  capable	  of	  forming	  a	  G-­‐quadruplex	  (Law	  et	  al.,	  2010),	  a	  property	  that	  could	  contribute	  to	  their	  specific	  targeting	  to	  telomeres	  and	  pericentric	  heterochromatin	  (Drané	  et	  al.,	  2010;	  Goldberg	  et	  al.,	  2010).	  	  In	   conclusion,	   the	   HIRA	   complex	   provides	   a	   nucleosome	   gap-­‐filling	   strategy	   that	  may	  operate	  in	  all	  instances,	  although	  the	  interaction	  of	  the	  HIRA	  complex	  with	  Pol	  II	  may	  provide	   additional	   targeting.	   H3.3	   deposition	   by	   HIRA	   at	   naked	   DNA	   may	   be	   part	   of	   a	  salvage	  pathway	  that	  acts	  to	  avoid	  leaving	  nucleosome-­‐free	  DNA	  regions.	  This	  mechanism	  might	  be	  especially	  critical	  after	  DNA	  replication	  to	  prevent	  chromatin	  defects	  at	  the	  level	  of	  the	  nucleosomal	  structure	  for	  instance	  during	  rapid	  divisions	  in	  early	  development	  (Ray-­‐Gallet	   et	   al.,	   2002)	   or	   to	   control	   unwanted	   cryptic	   transcription	   (Anderson	   et	   al.,	   2010).	  	  Evaluating	   to	  which	   extent	   the	   use	   of	   the	   alternative	   pathway	   fully	   restores	   preexisting	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function	  will	  be	  important	  in	  particular	  during	  development	  when	  specific	  marking	  have	  to	  be	   set	   in	   place.	   Finally,	   it	   will	   be	   of	   interest	   to	   investigate	   whether	   challenges	   to	  nucleosomal	  organization	  may	  make	  cells	  more	  dependent	  on	  such	  a	  protective	  pathway,	  during	  stress	  or	  DNA	  damage	  and	  according	  to	  developmental	  context.	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EXPERIMENTAL	  PROCEDURES	  
	  
Human	  cell	  lines	  	  We	  established	  cell	   lines	  stably	  expressing	  H3.1-­‐SNAP-­‐3XHA	  or	  H3.3-­‐SNAP-­‐3XHA	  in	  HeLa	  cells.	  The	  H3.1	  or	  H3.3	  ORFs	  were	  amplified	   from	  cDNA	  by	  PCR	  and	  cloned	  between	   the	  KpnI/XhoI	  sites	  of	  pCENP-­‐A–SNAP–3XHA	  (Jansen	  et	  al.,	  2007)	  replacing	  the	  CENP-­‐A	  gene.	  The	  resulting	  H3.1-­‐SNAP-­‐3XHA	  or	  H3.3-­‐SNAP-­‐3XHA	  ORFs	  were	  subcloned	  into	  pBABE	  and	  used	   for	   retroviral	   production	   and	   delivery	   into	   HeLa	   cells	   essentially	   as	   described	  previously	  (Shah	  et	  al.,	  2004).	  We	  selected	  them	  by	  Blasticidin	  S	  (5	  μg/ml;	  Calbiochem)	  and	  isolated	   monoclonal	   lines	   by	   flow	   cytometry.	   We	   verified	   the	   low	   expression	   levels	   of	  tagged	  H3.1	  and	  H3.3	  as	  compared	  to	  the	  endogenous	  counterparts	  to	  be	  able	  to	  use	  them	  as	  tracers	  (data	  not	  shown).	  
	  
H3-­‐SNAP	  labeling	  in	  vivo	  The	  SNAP	  labeling	  protocol	  is	  as	  described	  (Jansen	  et	  al.,	  2007).	  We	  added	  to	  cell	  medium	  at	  37°C	  10	  µM	  of	  SNAP-­‐Cell	  Block	  (Biolabs)	  during	  30	  min	  to	  quench	  SNAP-­‐tag	  activity	  or	  2	  
µM	  of	  SNAP-­‐Cell	  TMR-­‐Star	  (Biolabs)	  during	  20	  min	  for	  pulse	  labeling.	  After	  washing	  cells	  with	   prewarmed	   PBS,	   reincubation	   in	   complete	   medium	   for	   30	   min	   allowed	   excess	  compound	   to	  diffuse	   from	   cells	   and	   then	   cells	  were	  washed	   again	   in	  PBS.	   For	   the	   chase,	  incubation	  of	  cells	  was	  for	  2	  hrs	  in	  complete	  medium	  at	  37°C.	  After	  in	  vivo	  labeling,	  the	  cells	  (with	   or	   without	   triton	   pre-­‐extraction)	   were	   either	   directly	   used	   for	   SNAP	   labeling	  visualization	  by	  microscopy	  or	  processed	  for	  immunostaining.	  Alternatively,	  we	  harvested	  cells	  in	  Laemmli	  buffer	  (with	  or	  without	  triton	  pre-­‐extraction)	  to	  prepare	  cell	  extracts	  for	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NuPAGE	   bis-­‐tris	   4-­‐12%	   gel	   migration	   in	   MOPS	   buffer	   (Invitrogen)	   and	   fluorescence	  visualization	  in	  gel	  using	  a	  Typhoon	  FLA	  9000	  (GE	  Healthcare-­‐Life	  Sciences).	  Fluorescence	  signal	  was	  estimated	  using	  ImageJ	  software	  after	  normalization	  using	  Coomassie	  staining.	  	  
Microscopy	  analysis	  and	  quantification	  of	  TMR	  signal	  	  To	  quantify	  fluorescence	  intensity	  (TMR	  signal)	  in	  the	  acquired	  images	  we	  used	  the	  ImageJ	  software.	   We	   first	   defined	   background	   fluorescence	   by	   measuring	   the	   mean	   gray	   value	  (gray	  value	  divided	  by	  the	  area)	   from	  an	  area	  containing	  no	  nucleus.	  We	  then	  subtracted	  this	  general	  background	  in	  each	  image	  and	  quantified	  the	  mean	  gray	  value	  in	  each	  nucleus,	  that	  we	  called	  «	  fluorescence	   intensity	  ».	  Only	  TMR	  positive	  nuclei	  were	  subjected	   to	   this	  quantification	   on	   series	   of	   at	   least	   100	   and	   300	   nuclei	   for	   H3.1	   and	   H3.3,	   respectively	  (mean	   =	   397	   ±	   33	   for	   H3.1	   and	   479	   ±	   36	   for	   H3.3)	   in	   each	   experiment.	   The	   average	  fluorescence	   intensity	   was	   calculated	   for	   each	   condition	   in	   each	   experiment	   and	  normalized	   to	   sicont.	   At	   least,	   three	   independent	   experiments	   were	   performed	   for	   each	  siRNA	  condition	  and	  we	  applied	  a	  Mann	  and	  Whitney	  statistical	  test	  using	  the	  R	  software.	  	  
Immunofluorescence	  and	  replication	  sites	  visualization	  We	  carried	  out	  pre-­‐extraction	  of	  cells	  prior	  to	  fixation	  for	  5	  min	  with	  0.5%	  Triton	  in	  CSK	  buffer	  (10	  mM	  PIPES	  pH	  7,	  100	  mM	  NaCl,	  300	  mM	  sucrose,	  3	  mM	  MgCl2)	  in	  the	  presence	  of	  protease	  inhibitors	  as	  in	  (Martini	  et	  al.,	  1998)	  and	  we	  fixed	  cells	  in	  2%,	  paraformaldehyde.	  Non-­‐pre-­‐extracted	   cells	  were	   permeabilized	   5	  min	  with	   0.2%	  Triton	   in	   PBS.	  We	  blocked	  cells	   with	   BSA	   (5%	   in	   PBS	   plus	   0.1%	   Tween)	   before	   incubation	   with	   primary	   and	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secondary	  antibodies	  and	  DAPI	  staining.	  Coverslips	  were	  mounted	  in	  Vectashield	  medium.	  We	  used	  a	  Leica	  widefield	  microscope	  (40x	  objective)	  	   We	   labeled	  replication	  sites	   in	  vivo	  by	  a	  20	  min	  EdU	  pulse	  concomitantly	  with	   the	  TMR-­‐Star	   pulse.	   We	   visualized	   EdU	   using	   Click-­‐iT	   EdU	   Alexa	   Fluor	   488	   imaging	   kit	  (Invitrogen)	   on	   cells	   pre-­‐extracted	   or	   not	   with	   Triton	   before	   fixation.	   EdU,	   which	   is	   a	  nucleoside	  analog	  of	  thymidine,	  incorporates	  into	  DNA	  during	  active	  DNA	  synthesis	  in	  vivo.	  Contrary	  to	  BrdU,	  EdU	  detection	  does	  not	  require	  DNA	  denaturation	  for	  its	  detection	  and	  thus	   preserves	   TMR-­‐Star	   fluorescence.	   EdU	   detection	   can	   be	   followed	   by	  immunofluorescence	  using	  the	  above-­‐described	  protocol.	  	  
H3.3	  ChIP	  and	  ChIP-­‐seq	  We	  performed	  mononucleosome	  purification	  from	  the	  HeLa	  S3	  H3.3-­‐FLAG-­‐HA	  cell	   line	  as	  in	   (Loyola	   et	   al.,	   2006)	   and	   recovered	   immunoprecipitated	   DNA	   after	   proteinase	   K	  digestion,	  phenol	  chloroform	  extraction	  followed	  by	  ethanol	  precipitation.	  We	  used	  100ng	  of	  DNA	   for	   library	  preparation	  and	  performed	  DNA	  sequencing	  on	  an	   Illumina	  GA	   IIx	  by	  Fasteris-­‐SA	   (Ch.	   du	   Pont-­‐du-­‐Centenaire	   109	   CH-­‐1228	   Plan-­‐les-­‐Ouates	   Switzerland)	  following	  the	  Illumina	  protocol.	  	  
	  
ChIP-­‐seq	  data	  analysis	  	  We	  analyzed	  a	  number	  of	  previously	  published	  ChIP-­‐seq	  datasets	   in	  mouse	  ES	  cells:	  HA-­‐tagged	   H3.3	   in	   wild-­‐type	   and	   HIRA	   -­‐/-­‐	   cells	   (Goldberg	   et	   al.,	   2010),	   H3K4me3	   and	  H3K4me1	   (Goldberg	   et	   al.,	   2010),	   H3K27ac	   (Creyghton	   et	   al.,	   2010),	   H3K27me3	   (Rugg-­‐Gunn	   et	   al.,	   2010),	   RNA	   Pol	   II	   Ser5P	   and	   Ser2P	   (Rahl	   et	   al.,	   2010)	   and	   13	   transcription	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factors	  (cMyc,	  CTCF,	  E2F1,	  ESRRB,	  KLF4,	  NANOG,	  nMyc,	  OCT4,	  SOX2,	  STAT3,	  TCFCP2I1	  and	  ZFX)	  together	  with	  a	  GFP	  control	  (Chen	  et	  al.,	  2008).	  The	  Hela	  H3.3	  ChIP-­‐seq	  was	  mapped	  in	  the	  same	  way	  to	  the	  human	  genome	  (assembly	  Hg18).	  	  (See	  supplemental	  information)	  
	  
Purification	  of	  recombinant	  proteins.	  	  	  The	   recombinant	   trimeric	   complex	   HIRA(His)-­‐UBN1(Flag)-­‐Cabin1(myc)	   and	   individual	  proteins	   HIRA(Flag),	   UBN1(Flag),	   Cabin1(Flag)	   and	   His-­‐Asf1a	   were	   expressed	   in	  baculovirus	  infected	  Sf9	  and	  purified	  as	  described	  in	  supplemental	  information.	  	  
DNA	  binding	  assay	  Bead-­‐linked	  plasmid	  DNA	  (PUC19)	  substrate	  was	  obtained	  as	  previously	  described	  (Mello	  et	  al.,	  2004).	  Mock-­‐beads	  or	  DNA-­‐beads	  were	  blocked	  with	  BSA	  (1	  mg/ml)	  and	  incubated	  1hr	   at	   30°C	  with	   20	  µg	   of	  HeLa	   nuclear	   extracts	   or	  ≈200	   ng	   of	   recombinant	   proteins	   in	  buffer	  containing	  10	  mM	  Hepes	  pH	  7.8,	  2	  mM	  MgCl2,	  1mM	  CaCl2,	  0.5	  mM	  EGTA,	  100	  mM	  NaCl,	  0.1%	  NP40	  and	  8%	  glycerol	  in	  a	  final	  volume	  of	  50	  µl.	  Then,	  the	  beads	  were	  washed	  three	  times	  in	  the	  presence	  of	  300	  mM	  NaCl	  and	  0.5%	  NP40.	  Bound	  proteins	  were	  analyzed	  by	  western	  blot.	  	  	  
Digestion	  of	  nuclei	  with	  DNase	  We	  carried	  out	  digestion	  with	  DNase	  (RQ1,	  Promega)	  on	  nuclei	  isolated	  from	  96	  hr	  siRNA-­‐treated	   HeLa	   H3.3-­‐SNAP	   cells.	   Digestion	   products	   were	   analysed	   by	   agarose	   gel	  
	   26	  
electrophoresis	  followed	  by	  ethidium	  bromide	  staining	  for	  visualizion	  using	  a	  Typhoon	  FLA	  9000	  (GE	  Healthcare-­‐Life	  Sciences).	  Plot	  profiles	  were	  obtained	  using	  ImageJ	  software.	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ACCESSION	  NUMBER	  Our	  Hela	  S3	  H3.1/H3.3	  ChIP-­‐seq	  datasets	  have	  been	  deposited	  in	  the	  GEO	  database	  with	  the	  accession	  number	  GSE31794.	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FIGURE	  LEGENDS	  	  	  	  	  	  	  	  	  	  	  
	  
Figure	   1.	   An	   in	   vivo	   visualization	   assay	   for	   newly	   synthesized	   H3.1	   and	   H3.3	  
deposition	  	  
(A)	   Fluorescent	   microscopy	   visualization	   of	   H3.1-­‐	   and	   H3.3-­‐SNAP	   after	   in	   vivo	   labeling	  assays	   with	   red	   fluorescent	   TMR-­‐Star	   in	   Pulse,	   Quench-­‐Pulse	   and	   Quench-­‐Chase-­‐Pulse	  experiments.	   The	   Pulse	   labels	   pre-­‐existing	   H3-­‐SNAP,	   the	   Quench-­‐Pulse	   quenches	   pre-­‐existing	   H3-­‐SNAP	  with	   non-­‐fluorescent	   Block	   preventing	   their	   subsequent	   labeling	   with	  TMR-­‐Star	   (background)	   and	   the	   Quench-­‐Chase-­‐Pulse	   labels	   new	   H3-­‐SNAP	   synthesized	  during	  the	  2	  hr-­‐chase	  (see	  figure	  S1).	  Either	  total	  (-­‐triton)	  or	  incorporated	  (+triton)	  H3.1-­‐	  and	  H3.3-­‐SNAP	  are	  visualized.	  Scale	  bar,	  10	  µm.	  
(B)	   Gel	   analysis	   of	   total	   (-­‐triton)	   or	   incorporated	   (+triton)	  H3.1-­‐	   and	  H3.3-­‐SNAP	  after	   in	  
vivo	   labeling	   assays	   in	   Pulse	   (P),	   Quench-­‐Pulse	   (QP)	   and	   Quench-­‐Chase-­‐Pulse	   (QCP)	  experiments.	   Extracts	   from	   labeled	   cells	   (-­‐triton	   or	   +triton)	   were	   used	   for	   NuPAGE	   gel	  electrophoresis.	  The	  fluorescent	  bands	  corresponding	  to	  the	  labeled	  H3.1-­‐	  and	  H3.3-­‐SNAP	  were	   visualized	   and	   quantified	   after	   normalization	   to	   Coomassie	   staining.	  We	   calculated	  the	  ratios	  of	  H3.1/H3.3	  for	  new	  total	  and	  new	  incorporated	  labeled	  histones,	  respectively.	  The	   indicated	   ratios	   correspond	   to	   the	   average	   value	   derived	   from	   four	   experiments.	  Standard	  deviations	  for	  the	  total	  new	  H3.1/H3.3	  ratio	   is	  0.08	  and	  for	  newly	   incorporated	  0.03	  (n=4).	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Figure	  2.	  Newly-­‐deposited	  H3.1	  overlaps	  with	  the	  replication	  sites	  in	  vivo,	  while	  H3.3	  
does	  not	  	  
(A)	   Scheme	   of	   the	   assay	   for	   in	   vivo	   labeling	   new	   incorporated	   H3.1	   and	   H3.3	   by	   the	  Quench-­‐Chase-­‐Pulse	   experiment	   and	   replication	   sites	   with	   EdU.	   Cells	   are	   treated	   with	  triton	  before	  fixation	  to	  visualize	  incorporated	  histones	  only.	  
(B)	  (Left)	  Fluorescent	  microscopy	  visualization	  of	  replication	  sites	  (EdU,	  green)	  and	  of	  new	  incorporated	  H3.1	  and	  H3.3	  (red)	  after	   in	  vivo	   labeling.	  The	  white	  and	  green	  arrowheads	  indicate	   typical	   negative	   and	   positive	   EdU	   cells,	   respectively.	   Scale	   bar,	   10	   µm.	   (Right)	  Graph	  representation	  of	  the	  percentage	  of	  H3.1	  and	  H3.3	  cells	  negative	  (EdU	  -­‐)	  or	  positive	  (EdU	  +)	   for	   EdU	   staining	  which	   are	   labeled	  with	  TMR-­‐Star.	   Error	   bars	   indicate	   standard	  deviation	  in	  at	  least	  three	  experiments.	  
(C)	  Fluorescent	  microscopy	  visualization	  of	  the	  different	  patterns	  of	  replication	  sites	  (EdU,	  green)	  during	  early,	  mid	  or	  late	  S	  phase	  and	  of	  new	  incorporated	  H3.1	  and	  H3.3	  (red)	  after	  
in	  vivo	   labeling	  by	  a	  Quench-­‐Chase-­‐Pulse	  experiment.	  Insets	  represent	  enlarged	  images	  of	  selected	  area.	  Scale	  bar,	  10	  µm.	  	  
Figure	  3.	  Alternative	  deposition	  of	  H3.3	  at	  replication	  sites	  when	  H3.1	  incorporation	  
is	  impaired	  by	  CAF-­‐1	  depletion	  
(A)	  Scheme	  of	  the	  assay	  for	  labeling	  new	  incorporated	  H3.1	  and	  H3.3	  by	  the	  Quench-­‐Chase-­‐Pulse	   experiment	   and	   replication	   sites	   with	   EdU	   during	   the	   Pulse,	   coupled	   with	  transfection	   of	   siRNA	   against	   CAF-­‐1	   p60	   (sip60#1)	   or	   control	   48	   hr	   before	   the	   in	   vivo	  labeling.	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  (B)	  (Left)	  Fluorescent	  microscopy	  visualization	  of	  replication	  sites	  (EdU,	  green)	  and	  new	  incorporated	  H3.1	   or	  H3.3	   (red)	   after	   siRNAs	   transfection	   against	   CAF-­‐1	   p60	   or	   control.	  CAF-­‐1	   p60	   is	   detected	   by	   immunofluorescence	   (blue).	   The	   insets	   represent	   enlarged	  images	  of	  one	  selected	  cell.	  Scale	  bar,	  10	  µm.	  (Right)	  Graph	  showing	  the	  sip60/sicont	  ratio	  corresponding	   to	   TMR	   fluorescence	   intensity	   for	   H3.1	   and	   H3.3.	   Error	   bars	   indicate	  standard	   deviation	   in	   at	   least	   three	   experiments.	   A	   Mann	   and	   Whitney	   statistical	   test	  established	   the	   significance	   of	   the	   difference	   between	   sip60	   and	   sicont	   (for	  H3.1	   p=0.02	  and	  H3.3	  p=0.35).	  	  
(C)	   (Top)	  Scheme	  of	   the	  assay	   for	   labeling	  new	   incorporated	  H3.3	  by	   the	  Quench-­‐Chase-­‐Pulse	   experiment	   and	   replication	   sites	   with	   EdU	   during	   the	   Pulse,	   coupled	   with	  transfection	   of	   siRNAs	   before	   the	   in	   vivo	   labeling.	   We	   counted	   the	   cells	   presenting	  overlapping	  TMR	  and	  EdU	   signals.	   (Bottom,	   left)	  Western	  blotting	  on	   total	   extracts	   from	  siRNA-­‐treated	   cells	   to	   verify	   efficiency	   of	   the	   indicated	   siRNAs.	   (Bottom,	   right)	   Graph	  showing	   the	   percentage	   of	   EdU	   positive	   cells	   with	   TMR	   and	   EdU	   overlapping	   in	   the	  indicated	   siRNAs-­‐treated	   cells.	   Error	   bars	   indicate	   standard	   deviation	   in	   at	   least	   three	  experiments.	  	  
Figure	  4.	  Depletion	  of	   the	  HIRA	   complex	   severely	   affects	   the	  de	  novo	   deposition	  of	  
H3.3	  without	  permitting	  significant	  H3.1	  incorporation	  throughout	  the	  cell	  cycle.	  
(A)	  Western	   blot	   analysis	   of	   (Left)	   anti-­‐HA	   immunoprecipitates	   from	  nuclear	   extracts	   of	  cells	   expressing	   SNAP-­‐tagged	   H3.1	   or	   H3.3,	   (Middle)	   immunoprecipitates	   from	   nuclear	  extracts	   of	   cells	   expressing	   H3.3	   with	   antibodies	   against	   HIRA,	   Cabin1,	   UBN1	   or	   rabbit	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(rIgG)	  and	  mouse	  (mIgG)	  IgG	  controls	  	  and	  (Right)	  total	  extracts	  from	  cells	  treated	  with	  the	  indicated	  siRNAs.	  Input	  corresponds	  to	  10%	  of	  nuclear	  extract	  used	  for	  each	  experiment.	  
(B)	  Scheme	  of	  the	  assay	  for	  labeling	  new	  incorporated	  H3.1	  and	  H3.3	  by	  the	  Quench-­‐Chase-­‐Pulse	   experiment	   coupled	   with	   transfection	   of	   siRNAs	   against	   Cabin1,	   UBN1,	   HIRA	  (siHIRA#1)	  or	  control	  72	  hr	  before	  the	  in	  vivo	  labeling.	  	  
(C).	   (Left)	   Fluorescent	   microscopy	   visualization	   of	   new	   incorporated	   H3.1	   (red)	   after	  treatment	   with	   the	   indicated	   siRNAs.	   Cabin1,	   UBN1	   or	   HIRA	   are	   revealed	   by	  immunofluorescence	   (green).	   Scale	   bar,	   10	  µm.	   (Right)	   Graph	   showing	   the	   ratio	   of	   TMR	  fluorescence	   intensity	  siRNA/sicont	   for	  H3.1.	  Error	  bars	   indicate	  standard	  deviation	   in	  at	  least	   three	   experiments.	   The	   statistical	   significance	   of	   the	   difference	   between	   siRNA	  and	  sicont	  was	  analyzed	  using	  a	  Mann	  and	  Whitney	  test	  (for	  siHIRA	  p=0.17,	  siUBN1	  p=0.01	  and	  siCabin1	  p=0.35).	  
(D)	  As	  panel	  C	  but	  for	  H3.3.	  The	  statistical	  significance	  of	  the	  difference	  between	  siRNA	  and	  sicont	  was	  analyzed	  using	  a	  Mann	  and	  Whitney	  test	  (for	  siHIRA	  p=0.02,	  siUBN1	  p=0.01	  and	  siCabin1	  p=0.35).	  The	  statistical	  significance	  of	  the	  difference	  between	  H3.1	  and	  H3.3	  was	  tested	  using	  a	  Mann	  and	  Whitney	  test	  :	  for	  siHIRA	  p=0.02	  and	  UBN1	  p=0.05.	  	  
Figure	  5.	  A	  link	  between	  HIRA	  complex-­‐dependent	  H3.3	  deposition	  and	  RNA	  pol	  II	  
(A-­‐C)	  ChIP-­‐seq	  density	  profiles	  of	  histone	  variant	  H3.3	  in	  human	  Hela	  S3	  cells	  expressing	  H3.3-­‐FLAG-­‐HA	   (A)	   and	  wild-­‐type	   (B)	   and	  HIRA-­‐/-­‐	  (C)	  mouse	   ES	   cells	   (mESCs)	   expressing	  tagged	  endogenous	  H3.3,	  within	  the	  gene	  body	  and	  up	  to	  5kb	  upstream	  and	  downstream	  of	  800	   highly	   expressed	   (red),	  medium	   expressed	   (blue)	   and	   low	   expressed	   (black)	   genes.	  H3.3	   data	   in	   mESCs	   is	   from	   (Goldberg	   et	   al.,	   2010).	   TSS:	   Transcription	   Start	   Site,	   TTS:	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Transcription	  Termination	  Site.	  Note	  we	  carried	  out	  chromatin	  preparation	  under	  high	  salt	  conditions	   (450	  mM	  NaCl)	  meaning	  we	   potentially	   lost	   the	   unstable	   H3.3/H2A.Z	   double	  variant	  known	  to	  be	  enriched	  at	  promoters	  (Jin	  et	  al.,	  2009).	  
(D-­‐E)	  ChIP-­‐seq	  density	  profiles	  of	  RNA	  pol	   II	  Ser5	  and	  Ser2	  phosphorylated	  forms	  in	  WT	  mESCs.	  RNA	  pol	  II	  data	  is	  from	  (Rahl	  et	  al.,	  2010).	  
(F-­‐G)	   ChIP-­‐seq	   density	   profiles	   for	   H3.3	   and	   RNA	   pol	   II	   (Ser5	   and	   Ser2	   phosphorylated	  forms)	  within,	  and	  up	  to	  2kb	  either	  side	  of,	  intergenic	  binding	  sites	  for	  two	  representative	  factors,	  E2F1	  and	  SOX2,	  active	  in	  mESCs.	  Binding	  sites	  were	  identified	  using	  ChIP-­‐seq	  data	  from	   (Chen	   et	   al.,	   2008).	   SOX2	   binding	   sites	   show	   an	   increase	   of	   H3.3	   level	   in	   HIRA-­‐deficient	  cells	  as	  compared	  to	  wild-­‐type	  mESCs	  that	  is	  likely	  an	  artefact	  of	  the	  reduction	  in	  HIRA-­‐dependent	  transcription	  factor	  sites	  rather	  than	  an	  absolute	  increase	  in	  the	  level	  of	  H3.3	   enrichment,	   as	   there	   is	   now	   a	   redistribution	   of	   a	   similar	   number	   of	   total	   sequence	  reads	  across	  a	   smaller	  number	  of	  HIRA-­‐independent	   transcription	   factor	  sites.	  The	  ChIP-­‐seq	   enrichment	   of	   Pol	   II	   we	   detect	   at	   most	   of	   these	   binding	   factors	   may	   reflect	   active	  transcription	  recently	  shown	  to	  play	  a	  role	  in	  enhancer	  function	  (Mattick,	  2010),	  although	  the	  predominant	  enrichment	  of	  Pol	  II	  Ser5P	  suggests	  it	  is	  more	  likely	  to	  be	  the	  capturing	  of	  looped	  enhancer-­‐promoter	  interactions	  during	  the	  crosslinking	  step	  of	  the	  ChIP.	  
(H)	  Mean	  levels	  of	  RNA	  pol	  II	  Serine	  5	  inside	  the	  intergenic	  binding	  sites	  is	  correlated	  with	  
ΔH3.3,	  a	  measure	  of	  the	  change	  in	  mean	  levels	  of	  H3.3	  within	  binding	  sites	  between	  wild-­‐type	   and	   HIRA	   deficient	   mESCs	   (see	   Methods).	   Values	   below	   1	   (grey	   line)	   represent	   a	  greater	   proportion	   of	   sites	   dependent	   on	   HIRA	   mediated	   H3.3	   deposition,	   while	   those	  above	  1	  represent	  a	  lower	  proportion.	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(I)	   Western	   blot	   analysis	   of	   immunoprecipitates	   from	   nuclear	   HeLa	   extracts	   with	  antibodies	  against	  Cabin1,	  UBN1	  or	  rabbit	  IgG	  control	  showing	  the	  co-­‐immunoprecipitation	  of	  RNA	  polymerase	  II	  phosphorylated	  at	  Ser2	  (left)	  and	  at	  Ser5	  (right).	  Input	  corresponds	  to	  10%	  of	  nuclear	  extract	  used	  for	  each	  experiment.	  
(J)	  Western	  blot	  analysis	  of	   immunoprecipitates	   from	  HeLa	  nuclear	  extracts	  with	  specific	  antibodies	   against	   RNA	   polymerase	   II	   Ser2P	   and	   its	   mouse	   IgM	   control	   (left)	   or	   RNA	  polymerase	   II	   Ser5P	   and	   its	   mouse	   IgG	   control	   (right)	   showing	   that	   both	   RNA	   pol	   II	  antibodies	  co-­‐immunoprecipitated	  Cabin1,	  UBN1	  and	  HIRA.	   Input	  corresponds	   to	  10%	  of	  nuclear	  extract	  used	  for	  each	  experiment.	  	  
Figure	  6.	  The	  HIRA	  complex	  binds	  directly	  to	  DNA	  and	  its	  depletion	  increases	  DNase	  
sensitivity	  	  
(A)	  Western	   blot	   analysis	   of	   DNA	   binding	   assay	   using	   nuclear	   extracts	   from	  HeLa	   cells.	  Input	  corresponds	  to	  50%	  of	  nuclear	  extract	  used	  for	  the	  experiment.	  
(B)	   (Left)	  Recombinant	  HIRA	  complex	  analyzed	  by	  NuPAGE	  and	  Coomassie	  stain.	   (Right)	  Western	  blot	  analysis	  of	  DNA	  binding	  assay	  using	  the	  HIRA	  complex.	  Input	  corresponds	  to	  100%	  of	  HIRA	  complex	  used	  for	  the	  experiment.	  
(C)	   (Left)	  UBN1,	  HIRA,	  Cabin1	  and	  Asf1a	  recombinant	  proteins	  analyzed	  by	  NuPAGE	  and	  Coomassie	   stain.	   (Right)	  Western	   blot	   analysis	   of	   DNA	   binding	   assay	   using	   each	   protein	  individually.	  Input	  corresponds	  to	  50%	  of	  protein	  used	  for	  the	  experiment.	  
(D)	  (Left)	  Assessment	  of	  the	  efficiency	  of	  96	  hr	  siRNAs	  treatment	  against	  HIRA	  by	  Western	  blotting	  of	  total	  extracts.	  (Right)	  Analysis	  of	  the	  DNase-­‐digestion	  products	  (time	  0,	  30	  sec,	  1	  min,	  2	  min	  and	  5	  min)	  carried	  out	  on	  nuclei	   isolated	   from	  siHIRA-­‐	  or	  sicont-­‐treated	  cells	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(total	  DNA).	  Densitometric	  profiles	  of	  the	  5-­‐min	  digestion	  products	  are	  shown.	  Profiles	  are	  normalized	  to	  the	  peak	  of	  maximum	  intensity.	  	  
Figure	  7.	  Model	  for	  histone	  H3	  deposition	  Model	  for	  CAF-­‐1-­‐mediated	  DNA	  synthesis-­‐coupled	  (DSC)	  and	  HIRA	  complex-­‐mediated	  DNA	  synthesis-­‐independent	   (DSI)	   histone	   H3	   deposition.	   CAF-­‐1	   mediates	   H3.1	   deposition	  through	   its	   interaction	   with	   PCNA	   during	   replication	   (and	   DNA	   repair)	   while	   the	   HIRA	  complex	  mediates	   H3.3	   deposition	   broadly	   through	   binding	   to	   transient	   accessible	   non-­‐nucleosomal	  DNA	  during	  post-­‐replication,	  sperm	  reprogramming	  and	  any	  event	  generating	  transient	  naked	  DNA.	  In	  regions	  associated	  with	  RNA	  pol	  II	  (promoters,	  coding	  regions	  and	  a	  subset	  of	  cis-­‐regulatory	  elements),	   the	   interaction	  between	  the	  HIRA	  complex	  and	  RNA	  pol	   II	   facilitates	  H3.3	   deposition.	  When	   CAF-­‐1	   is	   depleted	   and	   therefore	  H3.1	   deposition	  impaired,	   the	   HIRA	   complex	   enables	   alternative	   H3.3	   incorporation	   at	   non-­‐nucleosomal	  DNA	  at	  sites	  of	  synthesis.	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INVENTORY OF SUPPLEMENTAL INFORMATION 
 
SUPPLEMENTAL FIGURES AND LEGENDS 
- Figure S1 related to main figure 1 shows a scheme of the assays for labeling H3-SNAP 
histones.  
- Figure S2 related to main figure 2 shows in vivo labeling of newly-synthesized H3-SNAP 
and of replication sites with EdU coupled or not with aphidicolin treatment to block 
replication. 
- Figure S3 shows control experiments related to main figure 3 and western blot analysis 
of extracts from H3.1 or H3.3 cells treated with siRNA against CAF-1p60 or control. 
- Figure S4 shows control experiments related to main figure 4 and western blot analysis 
of extracts from H3.1 or H3.3 cells treated with siRNA against HIRA, UBN1, Cabin1 or 
control. 
- Figure S5 related to main figure 4 shows in vivo labeling of newly-synthesized H3.3-
SNAP in cells treated with siRNAs against DAXX or ATRX. 
- Figure S6 shows ChIP-seq data analysis related to main figure 5. 
 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
- siRNA tranfection 
- Cell extracts, immunoprecipitation and Western blotting 
- Antibodies 
- Purification of recombinant proteins  
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SUPPLEMENTAL FIGURES AND LEGENDS  
 
Figure S1 (related to main figure 1) 
Scheme of the assays for labeling H3-SNAP histones in Pulse, Quench-Pulse and Quench-
Chase-Pulse experiments in vivo. The Pulse labels pre-existing H3-SNAP with red 
fluorescent TMR-Star, the Quench-Pulse quenches pre-existing H3-SNAP with non-
fluorescent Block preventing their subsequent labeling with TMR-Star and the "Quench-
Chase-Pulse" labels new H3-SNAP synthesized during the 2 hr-chase. Either total (-triton) 
or incorporated (non-soluble) (+triton) H3-SNAP are analyzed.  




Figure S2 (related to main figure 2)  
 (A) In vivo labeling scheme of newly-synthesized H3-SNAP by the Quench-Chase-Pulse 
experiment and of replication sites with EdU during the Pulse coupled or not with 
aphidicolin treatment to block replication. The cells are treated or not with triton before 
fixation to visualize incorporated or total H3-SNAP, respectively. 
(B) Fluorescent microscopy visualization of replication sites (EdU, green) and total or 
incorporated newly-synthesized H3.1- and H3.3-SNAP (red) after in vivo labeling in 






Figure S3 (related to main figure 3) 
 (A) Cell cycle profiles of HeLa H3.1 and HeLa H3.3 cells treated for 48 hr with siRNA 
against CAF-1 p60 or control. PI; Propidium Iodide. The efficiency of siRNA treatments 
shown in figure 3B is assessed by Western blotting of total extracts of H3.1 cells (-triton) 
treated with siRNAs against CAF-1 p60 (sip60#1) or control (sicont). 
(B) Quantification of the percentage of cells that are EdU positive after the indicated siRNA 
treatments for 48 hr. Error bars indicate standard deviation in at least three experiments. 
(C) (Left) Assessment of the efficiency of 48 hr siRNAs treatment against p60 by Western 
blotting of total extracts. (Right) Fluorescent microscopy visualization of replication sites 
(EdU, green) and new incorporated H3.1 or H3.3 (red) after siRNAs transfection against 
CAF-1 p60#1, CAF-1 p60#2 or control. CAF-1 p60 is detected by immunofluorescence 
(blue). The insets represent enlarged images of one selected cell. Scale bar, 10 m.   
 (D) Western blot analysis of the chromatin, nuclear and cytosolic fractions prepared from 
H3.1 or H3.3 cells treated for 48 hr with siRNA against CAF-1 p60 or control. The H3.1 and 
H3.3 decrease in the chromatin fractions by about 6-fold and 2-fold respectively supported 
the stronger impact of p60 depletion on new H3.1 incorporation (see Figure 3B). The 
presence of tagged histones in lower amounts in nuclear an cytosolic extracts from sip60-
treated cells suggests that depletion of CAF-1 may also have a general effect on histone 




Figure S4 (related to main figure 4) 
 (A) (Left) Cell cycle profiles of HeLa H3.1 and H3.3 cells treated for 72 hr with siRNA 
against HIRA, UBN1, Cabin1 or control. PI; Propidium Iodide. (Right) Quantification of the 
percentage of cells that are EdU positive after the indicated siRNA treatments for 72 hr. 
Error bars indicate standard deviation in at least three experiments. 
(B) (Left) Assessment of the efficiency of 72 hr siRNAs treatment against HIRA by Western 
blotting of total extracts. (Right) Fluorescent microscopy visualization of new incorporated 
H3.1 or H3.3 (red) after siRNAs transfection against HIRA#1, HIRA#2 or control. HIRA is 
detected by immunofluorescence (green). Scale bar, 10 m. 
 (C) and (D) Western blot analysis of chromatin, nuclear and cytosolic fractions prepared 
from H3.1 and H3.3 cells respectively treated for 72 hr with siRNA against Cabin1, HIRA, 
UBN1 or control. Chromatin fractions showed that in siCabin1-, siHIRA- or siUBN1-treated 
cells the amount of H3.1 did not change while H3.3 decreased by about 3-fold in both 
siHIRA- and siUBN1- but not in siCabin1-transfected cells. This supported the stronger 
impact of HIRA complex and UBN1 depletions on new H3.3 incorporation (see Figure 4C-D). 
Interestingly, we detected an increase of H3.3 but not of H3.1 in the nuclear and cytosolic 
extracts of siCabin1-treated cells suggesting that although Cabin1 is not a major player in 




Figure S5 (related to main figure 4) 
(A) (Left) In vivo labeling scheme of newly-synthesized H3.3-SNAP by the Quench-Chase-
Pulse experiment coupled with transfection of siRNAs against DAXX or ATRX 72hr before 
the in vivo labeling. The cells are treated or not with triton before fixation to visualize 
incorporated or total H3-SNAP, respectively. (Right) Assessment of the siRNAs efficiency by 
Western blotting of total extracts from cells treated with the indicated siRNAs. 
(B) Fluorescent microscopy visualization of total or incorporated newly-synthesized H3.3-
SNAP (red) after in vivo labeling. DAXX and ATRX are detected by immunofluorescence 
(green). Scale bar, 10 m. 
 9 
 10 
Figure S6 (related to main figure 5)  
(A) Histone modification patterns in and around three example sets of intergenic TFBS 
peaks (ZFX, OCT4 and STAT3) used in this study. All binding sites have low levels of 
H3K4me3 indicating they are unlikely to be part of promoters and low levels of H3K27me3, 
indicating they are not repressed. Binding sites are also enriched for H3K4me1 and 
H3K27ac, histone marks associated with active enhancers, although the pattern of 
enrichment in and around the binding site (delineated by two grey lines) differs 
significantly between factors. Profiles were created by summing read coverage per mapped 
read in 200bp sliding windows outside of the binding site and normalizing by the length of 
the window and the number of binding sites. Inside binding sites, the binding site was 
divided into 5 bins of equal length, and read coverage per mapped read was summed for 
each bin over all binding sites and then normalized by the total number of bases in each bin.  
(B) H3.3 levels in wild-type, HIRA-deficient and ATRX-deficient mESCs in and around three 
example sets of TFBS peaks (ZFX, OCT4 and STAT3) used in this study. All binding sites 
show distinct enrichment directly within the binding site (delineated by two grey lines). For 
some factors, H3.3 level in the binding site was reduced in HIRA deficient cells compared to 
wild-type cells (e.g. ZFX). For other factors, the level of H3.3 was higher in HIRA deficient 
cells than wild-type cells (e.g. OCT4) or remained virtually the same (e.g. STAT3). Note 
these are averaged profiles and therefore show only general trends, rather than what is 
true for each binding site in the set. There is a proportion of binding sites that are lower or 
higher in HIRA deficient cells in each case, but the proportion of these is different in each 
factor. Graphs were produced as described in (A).  
(C) A correlative analysis of mean H3.3 levels in wild-type mESCs in sets of 13 TFBS peaks 
and mean Pol II Ser5P in the same binding sites. A weak but significant correlation was 
found between H3.3 and Pol II levels, suggesting that Pol II influences H3.3 deposition in 
some TFBSs.  
(D) The same correlative analysis between mean H3.3 levels in HIRA deficient mESCs in 
TFBSs and mean Pol II Ser5P. The weak correlation seen for wild-type mESCs has now been 
completely abrogated, confirming that Pol II influences HIRA-dependent H3.3 deposition 
but not HIRA-independent H3.3 deposition. 
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SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
siRNA transfection 
Small interfering RNAs (siRNA) were purchased from Dharmacon. We used ON-
TARGETplus J-013610-07 (HIRA#1), J-013610-06 (HIRA#2), J-014195-05 (UBN1), J-
012454-09 (Cabin1), J-004420-05 (DAXX) and D-001810-01 (non-targeting control). 
SiRNAs p60#1 and p60#2 against CAF-1 p60 and siRNA against ATRX were previously 
described in (Polo et al., 2006) and (Ritchie et al., 2008), respectively. H3.1-SNAP or H3.3-
SNAP cells were transiently transfected using oligofectamine (Invitrogen) for siRNAs. 
 
Cell extracts, immunoprecipitation and Western blotting 
For total extracts, cells were lysed directly into Laemmli buffer sample followed by addition 
of benzonase (Novagen). Cytosolic and nuclear extracts were obtained as previously 
described (Martini et al., 1998). We prepared chromatin fraction by addition of benzonase 
to the final pellet followed by sonication. 
Immunoprecipitations were carried out overnight at 4°C with the appropriate 
primary antibody in the presence of 150 mM NaCl and 0.5% NP40 followed by an 
incubation with Dynabeads protein A, protein G or rat anti-mouse IgM (Invitrogen). For HA 
immunoprecipitation, we used anti-HA affinity matrix (Roche). 
For Western blot analysis, extracts or immunoprecipitated proteins were run on 
NuPAGE bis-tris 4-12% gels in MOPS buffer (Invitrogen) and transferred to nitrocellulose 
membrane (Protran). Primary antibodies were detected using horse-radish-peroxidase-
conjugated secondary antibodies (Jackson ImmunoResearch Laboratories) and SuperSignal 
enhanced chemiluminescent detection kit (Pierce). For semi-quantitative analysis of 
western blot, serial dilutions of protein samples were loaded in order to obtain comparable 
signals, in the linear range of detection. Chemiluminescent signal was quantified using the 
ChemiDoc system equipped with a XRS camera and Quantity One software (BioRad). 
 
Antibodies 
Antibodies were used at the following dilutions: anti-CAF-1p60 rabbit polyclonal (Green 
and Almouzni, 2003) western 1:1000 and IF 1:250; anti-CAF-1p150 mouse monoclonal 
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(ab7655, Abcam) 1:500; anti-CAF-1 p48 rabbit polyclonal (ab1765, Abcam) 1:1000; anti-
HIRA mouse monoclonal (WC119) (Hall et al., 2001) western and IF 1:100; anti-Cabin1 
rabbit polyclonal (ab3349, Abcam) western 1:1000 and IF 1:400; anti-UBN1 mouse 
monoclonal (ab84953, Abcam) western 1:500 or rabbit polyclonal (Banumathy et al., 2009) 
western 1:1000 and IF 1:500; anti--tubulin mouse monoclonal (T5326, Sigma) 1:1000; 
anti-HA epitope rat monoclonal (Roche) 1:1000; anti-H3 rabbit polyclonal (ab1791, Abcam) 
1:1000; anti-RNA polymerase II Ser2P mouse monoclonal (clone H5 #MMS-129R, Covance) 
1:500; anti-RNA polymerase II Ser5P mouse monoclonal (clone CTD4H8 #05-623, 
Millipore) 1:1000; anti-Asf1a/b rabbit polyclonal (Mello et al., 2002) 1:1000; anti-DAXX 
rabbit polyclonal (sc-7152, Santa Cruz); anti-ATRX rabbit polyclonal (sc-15408, Santa Cruz) 
1:2000; anti-spt6 rabbit polyclonal (ab32820, Abcam) 1:500; anti-spt16 rabbit polyclonal 
(sc-28734, Santa Cruz) 1:500; anti-NASP rabbit polyclonal (Cook et al., submitted); anti-
DEK rabbit polyclonal (NB100-61058, Novus Biologicals). 
 
Purification of recombinant proteins  
For HIRA(His)-UBN1(Flag)-Cabin1(myc) trimeric complex productions, 1 x 106 Sf9 cells/ml 
(of Sf900-III medium) (Invitrogen) were co-infected with viruses for each complex subunit, 
at an MOI of 1. Infected cells were harvested 48 hours post-infection. To purify protein 
complexes, cell pellets were lysed by Dounce homogenization in 20 mM Hepes pH 8.0, 500 
mM NaCl, supplemented with 5 mM 2-mercaptothanol and protease inhibitors. Clarified 
supernatants were incubated with anti-flag (M2) agarose (Sigma) for 1 hour. Bound 
protein(s) were washed with 60 column volumes of lysis buffer prior to elution with 
g/ml of flag (M2) peptide (Sigma) for 2 hours at 4°C. Subunit expression and complex 
composition was confirmed by Western Blot analysis. 
 Recombinant HIRA(Flag), UBN1(Flag), and Cabin1(Flag) were purified following the 
method described for the trimeric complex. Recombinant His-Asf1a was expressed in 
baculovirus infected Sf9 cells. Cell pellets were lysed in 20 mM Hepes pH 8.0, 500 mM NaCl, 
10 mM Imidazole, supplemented with 5 mM 2-mercaptothanol and protease inhibitors. The 
clarified supernatant was incubated with Ni-NTA resin (Qiagen) for 1 hour. The Ni-NTA 
resin was washed with 60 column volumes of lysis buffer supplemented with 40 mM 
Imidazole and bound protein was step-eluted with lysis buffer containing 250 mM 
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Imidazole. Peak fractions of His-Asf1a were further purified by size exclusion 
chromatography (Superdex 75, GE Healthcare) in 20 mM Hepes pH 8.0, 500 mM NaCl, and 5 
mM 2-mercaptothanol. 
 
ChIP-seq data analysis 
All datasets were downloaded as raw Illumina FASTQ reads from the Short Read Archive 
(http://www.ncbi.nlm.nih.gov/Traces/sra) and mapped to the mouse genome 
(NCBI37/mm9 assembly) using the Bowtie aligner (Langmead, 2010) retaining only unique 
hits with a maximum of 2 mismatches. RNA-seq analysis was used to obtain sets of high, 
medium and low expressed genes in Mouse ES cells (Guttman et al., 2010) and Human Hela 
S3 cells (Birney et al., 2007). We utilized RNA-seq data, rather than available microarray 
data, to obtain precisely the most abundantly expressed isoform for each gene in that cell 
type. This delineated the start and end of transcripts more precisely, which was important 
for the H3.3 and Pol II enrichment analysis. Paired end reads were treated as single-end 
reads and mapped to either the mouse or human genomes respectively (same assemblies) 
using TopHat (Trapnell et al., 2009) with default settings. Isoform quantification and 
expression levels was obtained using Cufflinks (Trapnell et al., 2010) using an input 
reference set of all known transcripts from the UCSC Known Gene table (Fujita et al., 2011). 
For each gene, any transcript isoform with an abundance of > 50% was chosen, otherwise 
the longest isoform was chosen. Any gene with a different gene within 5kb either side were 
removed from the list of genes, to avoid mixing signals. Transcripts were sorted by FPKM 
value (Fragments Per Kilobase of exon model per Million mapped fragments) and 800 
transcripts each were chosen for high (top 800), medium (800 around the mean FPKM 
value) and low expressed genes (bottom 800 with FPKM value > 0). Enrichment graphs 
were carried out using the ShortRead package (Morgan et al., 2009) implemented within 
the R statistical package. Genome-wide coverage maps were created using the coverage() 
function and, to represent the full nucleosome wrapped sequence, reads were extended to a 
length of 150bp in the direction of the read. Read coverage was normalized by the total 
number of mapped reads. To correct for any underling biases due to mappability, MNase 
digestion bias or the aneuploidy nature of the Hela cell line, we further normalized all mean 
IP signals by the mean input signal at each window across all genes.  
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Transcription factor binding site peaks were created for each factor from Bowtie 
mapping output using the FindPeaks4 program (v4.0.13) (Fejes et al., 2008). Reads were 
extended to a length of 150bp and peaks were created setting the subpeak parameter to 0.4 
(peaks are split if there is a subpeak that falls 40% below the maximum peak), the trimming 
parameter to 0.2 (peaks are trimmed once they fall below 20% of the maximum peak 
height) and a p-value threshold of P<1e-4. The GFP input dataset was used as a background 
control. Peaks were filtered out if located within 2.5kb of a known mouse transcript 
(downloaded from the RefSeq, Ensembl or Known genes tables from the UCSC genome 
browser), a set of novel lncRNAs identified in mESCs (Guttman et al., 2009) or within 2kb of 
another peak from the same factor (to avoid mixing signals). Peaks were further filtered for 
the presence of H3K4me3 (to avoid any peaks located in novel promoter regions) by 
removing any peak covered by more than an average of 1 aligned read from the H3K4me3 
ChIP-seq dataset. In addition to a lack of H3K4me3, we found all sites were enriched for 
H3K4me1 and H3K27ac and had no enrichment for H3K27me3 (Figure S5), suggesting the 
sites were active regulatory elements in mESCs. We used the top 1000 remaining peaks 
(sorted by p-value) for each factor to allow for fair comparison between factors. To 
measure HIRA-dependent H3.3 deposition within a set of binding sites for a specific factor, 
we used a measure H3.3, calculated by dividing the mean H3.3 coverage in binding sites in 
HIRA deficient cells by mean H3.3 coverage in binding sites in wild-type cells. H3.3 values 
close to 1 represent little or no change in H3.3 coverage in HIRA deficient cells compared to 
WT, while those less than 1 represent an overall decrease and those above 1, an overall 
increase in mean H3.3 coverage. Mean coverage for a set of binding sites (carried out for 
H3.3 and Pol II) was measured as the sum of the number of extended reads per base per 
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